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Epidemiological and Experimental
Aspects of Metal Carcinogenesis:
Physicochemical Properties, Kinetics,
and the Active Species
by Laszlo Magos*
Thecarcinogenicpropertiesofselectedmetalsandtheircompoundsarereviewedtoprovideauseful referenceforex-
istingknowedgeonrelationshipsbetweenphysicalandchemicalforms,kineticsandcarcnogenic potentalandbetween
epqiemiology,bioassays, andshort-term testL Exteiveconsideationisgiventoarsenic,berl, cadmium,chromium,
lead,andnickel.Othermetassuchasantimony,cobalt, copper,iron,man selnium,andzincarediscussedbriefly.
Introduction
It is more than 100 years sincethe first reportofthepossible
carcinogenic activity ofarsenic appeared. In the intervening
period, more metals have been identified as carcinogenic and
research has expanded beyond epidemiology. Reviews (1-5)
usually accept that a) the carcinogenic activity of arsenic,
chromium, and nickel has been proved by epidemiological
studies; b) the evidence for the human carcinogenicity of
beryllium isinadequate orlimited; andc) atleastin someform
orin someexperimental conditions many moremetals areable
to induce tumors or to interact with genetic material.
Althoughepidemiologysuppliesthestrongestevidencefor an
associationbetween exposureandcarcinogenicity, ithas its own
limitations. Thefirst sourceofuncertaintyisthelackofinforma-
tion on exposure over a long period of time. Even follow-up
epidemiological studies, whichincorporate several criteria for
the analysis of the cause-and-effect relationship, use semi-
quantitative approximations and back extrapolations for ex-
posure classification. Thedistribution ofthemetal between its
differentchemical andphysical forms, which mayhavedifferent
carcinogenicpotential, gives a newdimensiontothisuncertainty.
The second sourceofuncertainty isconfounding variables like
age, socioeconomic status, smoking, and co-exposure to other
carcinogens at work. A third uncertainty may derive from the
longlatentperiodbetweenfirstexposureandtheonsetofcancer.
Thelatentperiod may belongerthanthetimebetweentheonset
ofexposureandthecut-offtimeofthestudy. Thefourth source
istheinsensitivityofepidemiological studies todetectlowrisk.
Therequirements fortheepidemiologicalstudyofcarcinogenici-
ty have been discussedby Doll (6) and errors found in several
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cohortstudies aretabulatedbytheU.S. Environmental Protec-
tionAgency (EPA) (7).
The selection ofexperimental conditions to fit the problem
makesanimalexperimentsaninvaluabletool fortheidentifica-
tionofcarcinogens. Animalexperimentscandeterminewhether
ametalinacertainform,dose, androuteofadministration can
induce cancer. Thedifficulty arises when none, oronly some,
ofthese conditions are relevant to human exposure. Thus, the
relevance ofinjection-site tumors, developed after the subcut-
aneousorintramuscularinjectionofhugedosesofinsolubleor
hardly solublemetalicpowdersorcompounds, isquestionable.
Itis notwithout interestthatacuteinflammatory reactions fol-
lowingintratracheal instillation orinhalationexposurearefre-
quently recorded, but injection site ulceration by definitely
ulcerogenicdoses(e.g.,ofcadmium)hasbeenseeminglyignored.
Research ontransportthrough cellmembranes (particles by
pinocytosis, solutesbydiffusionoractivetransport), metabolic
transformation includingvalency changes and solubility in ex-
tracellularandintracellularfluidshashelpedtogivereasonably
goodideasaboutthedeliveryofcarcinogenicmetalstothetarget.
Invtrotestshavehelpedtoidentifytheactiveform. Thus,kinetic
studiesand in vitroassays notonly supplement, buthelp to in-
terpret, epidemiological andexperimental data. Theyalsocon-
firmed the validity ofold-fashioned toxicological principles:
There is no effect without contact with the target, as the car-
cinogenictarget(inmostcases, geneticmaterial)iswithincells,
themetalcarcinogenmustpassthroughthecellmembrane;there
canbenoprimarybiochemical reactionwiththetargetwithout
themetal carcinogen being ina reactive form.
However, inspiteoftheconsiderableprogressmadetowardthe
identification ofmetal carcinogens, the mechanism by which
metalsexerttheircarcinogeniceffectsremainenigmaticforthe
following reasons: a)differentinvitroevaluationsystems(e.g.,
bacterialcellsversusmammaliancells)frequentlygivecontra-L. MAGOS
dictory results (8); b) many experimental conditions (e.g., in-
tramuscularadministration andhugesingledose)arenotsuitable
fortheidentificationofcrucial stepsinamultistageprocess; and
c) ascarcinogenic metals so far identified have nochemical or
biochemicalcharacteristics thatcannotbe foundin someother
metals (9,10), they are unlikely to act through a common
mechanism (like an importantgroupoforganic chemicals acts
through thealkylation ofDNA).
The uncertainties concerning the mechanism of metal car-
cinogenesis were reviewed by Furst (10), who concluded that
metal carcinogenesis does not follow the fundamental mech-
anisms oforganiccarcinogensandthecarcinogenicpotentialof
metals cannotbepredictedfromtheresultsofshort-termtests.
Theresultsofin vitrotestsareusedonly asguidesfortheiden-
tificationoftheactivespecies. Inagreementwiththisview, this
reviewdoes notattempttomakeanymechanisticgeneralizations,
butitsurveysdataonthechemical formsofmetalsatexposure;
the effectofthechemicalform atexposureonkineticsand car-
cinogenicity; and the active form ingenotoxic reactions.
Theunderlyingideabehindtheinclusionofkineticconsidera-
tionsafterepidemiology andanimalexperiments istobridgein-
formationontheinfluenceofchemicalformsatexposureoncar-
cinogenicity and onactivity in short-term tests.
Arsenic
Epidemiology
Thougharsenicwasthefirstmetalidentifiedasacarcinogen,
strongepidemiologicalevidencein supportoftheroleofarsenic
intheinductionofskinandlungcancer isrelativelynew(11,12).
Skincarcinomascausedbyarsenicareofthreetpes: basalcell
carcinoma, squamous cell carcinoma, and Bowen's disease
(epidermalsquamouscellcarcinoma).They aretheresultofpro-
longed ingestion ofinorganic arsenic in medicine ordrinking
water. Casereports suggestthatoccasionally skincanceris ac-
companied by cancer in internal organs (e.g., liver cancer,
especiallyhemangiosarcoma), butthisassociationhasnotbeen
confirmedby epidemiological studies (13).
The prolonged oral treatment of chronic dermatoses with
diluted Fowler's solution raised the prevalence ofskin cancer
above 20% in patients whose total dose exceeded 6 g (1).
Fowler's solution contained 3.8 g As/L in the form ofarsenic
trioxide. In Tiawan, a survey of more than 40,000 inhabitants
established a positive dose-response relationship between
arsenic indrinking water(As concentrationupto 1.8mg/L)and
skin cancer. Excess morbidity from skin cancer showed a
noticeable increasewhentotal Asdoseexceeded 10g. Alinear,
nonthresholdextrapolationindicatedthatthe lifetimeriskofskin
cancer from the daily oral intake of 1 mg inorganic arsenic is
12.5% (12). Themultistage-Weibull/time-dose-responsemodel
applied for the same data associated 1.3 x 10-3 lifetime risk
withtheingestionof 1 pgAs/kg/day(14). According tothelatest
study fromthe southwestern coastofTaiwan, arsenic indrink-
ing waterincreasedtheage-standardizedmortalityratios(SMRs)
ofskincancerdeathsofmalesandfemalesasfollows: < 0.3mg
As/L ofdrinking waterby 1.2- and3.2-fold; 0.3-0.59 As/Lby
2.02-and2.13-fold;0.59 < ngAs/Lby3.42-and4.32-fold(15).
Mostofthe cancermortality surveysforoccupationalgroups
are from copper smelters. The mortality experience of 8047
white smelter workers (U.S.) exposed to arsenic trioxide in-
dicated a3-foldincreaseinrespiratorycancer. Basedonurinary
arsenicconcentrations, exposurewasgradedasheavy, medium,
orlight. TheSMRwasashighas8-foldamongemployeeswho
hadbeenheavilyexposedformorethan 15years. However,asex-
posure to SO2 varied concomitantly with exposure to arsenic,
cancermortalityandexposuretoSO2alsoshowedasignificant
positivecorrelation(16). Whentheeffectofonecontaminantwas
adjusted forthepossibleconfoundingeffectoftheotheragent,
therelationshipofexcesscarcinogenicriskwitharseniclevelre-
mainedunchanged, butwithSO2levelitdisappeared. Owingto
the inverserelationshipbetweenageatinitialemploymentand
employmentyears, ageatinitialemploymentcorrelatedinversely
withthe SMRsofcancerdeaths. Nevertheless, the riskofcon-
tracting cancerwithinafixedtimeisincreasedwithageatinitial
employment(17).
In another study, the mortality experience of2801 smelter
workersemployedduringtheperiodof1940to 1964foratleast
1 yearwasfollowedthrough 1976. Therewere 100deathsdueto
lung cancer during the follow-up period. For the purpose of
cancerriskassessment, urinaryarsenicconcentrationwasabet-
terindexthanatmosphericconcentration(18,19). Ithasbeenalso
suggestedthatthetime-weightedexposureisamoreconsistently
reliablepredictorofrespiratarycancerriskthancumulativeex-
posure (20).
Acase-referentstudyfromaSwedishcoppersmelteratRonn-
skarfound significantly increased lung cancermortality in the
groupofcoppersmelterworkerswhohadbeenconsistentlyex-
posed to more than 0.5 mg As/m3 (21). Work in the roaster
department was associated with the highest risk of cancer,
especiallylungcancer(22). TWofollow-upstudiesusedthesame
cohort ofworkers employed for atleast3 months from 1928 to
1967. Inonestudythecohortwasrestrictedto3710workerswho
werealivein 1958whentheSwedishCancerRegisterwasopened
fortheregistrationofallnewly diagnosed cases ofcancer. Be-
tween 1958and 1982,461 cancerswereregisteredinthecohort.
The30% excessofcancerincidenceoverthegeneralpopulation
was mainly caused by lung cancer. Thus, compared with the
generalpopulationofSweden, theSMRforcancerincidenceat
all sites was 124andforlung cancerwas232. SMRsrelative to
thecountypopulationwere 133and355, respectively. Boththe
5 years' moving average of canccr incidence and mortality
declinedfrom 1975-1979to 1980-1984byaboutS0% (23). Inthe
second study, a positivedose-reponse relationship was found
between cumulative arsenic exposure (calculated from at-
mospheric concentration) and lung cancer mortality. Risk in-
creasedwiththeaverageintensity,butnottheduration,ofarsenic
exposure. Therewasnodose-responserelationshipbetweenex-
posure to SO2andlung cancer (24).
In a tin mining cooperative in China, a case-control study
compared the exposures toarsenic, radon, and tobacco of 107
employeeswithlungcancerwiththeexposuresofequalnumbers
ofage-matched tin miners without lung cancer. Exposure to
arsenicwascategorizedwiththeaverageexposureinmilligrams
percubicmetermultipliedbythemonthsofexposure. Thestudy
indicatedthattheriskoflungcancerincreaseddirecdywith ex-
posuretoarsenic,dependedmoreonthedurationthanonthein-
tensity ofarsenic exposure, andappearedtobeindependentof
exposuretotobacco. Thehighcorrelationbetweenarsenicand
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radon exposure made assessment to each agent alone pro-
blematic. However, atthelowestcategoryofradonexposurethe
relativeriskinthelow, middle, andhigharsenicexposuregroups
was 1, 2.7, and5.4, respectively. Atthelowestarsenic exposure
level, the relative riskoflung cancer was 1, 13.8, and2.2 inthe
low, middle, andhighradonexposuregroups, respectively (25).
Two studies (26,27) and the update of the first study (28)
recorded a3-fold excessofrespiratory cancer inemployees in-
volvedinthemanufactureofarsenic-containing insecticides. No
excessdeathsfromcancerweredetectedamongorchardworkers
in the United States (12,29). Though the use ofarsenic insec-
ticidesbywinegrowerswasabolishedinGermanysoonafterthe
WorldWarII, intheperiodof1960to 1976, onepathologydepart-
ment diagnosed lung cancer in 108 (66%) ofthe 163 deceased
winegrowerswithahistoryofchronicarsenicintoxication. Dur-
ing the sameperiod, thetrade associationofwinegrowers had
records on 417 deaths. Melanosis, hyperkeratosis, or multiple
skincarcinomas werefoundin250cases. Thefrequency oflung
carcinomas was65.5% whensignsofchronicarsenicpoisoning
werepresentand45.9% whenthey wereabsent. Theconcomi-
tantpresenceofskinandlungcarcinomas inwinegrowers isin
agreementwithinhalationexposureduringsprayingandoralex-
posuretoarsenicthroughtheconsumption ofHaustrunkmade
fromtheaqueousinfusionofpressedgrapes. Longfermentation
assuredanefficient removalofarsenic fromgrapeskinsandhigh
consumption (0.7-3.0Ldaily) resultedinhigharsenicintakesat
the time ofwork in vineyards (30).
According to occupational health surveys, increased cancer
riskisregularly associatedwithexposureresultinginlesionsof
skinandmucousmembranes(13,31,32). Thelackofanysimilar
observationonheavyconsumersofseafoodandthesignificantly
lowertoxicity oforganoarsenicals in seafood (33) suggest that
arsenobetaine is unlikely to be a human carcinogen. Epi-
demiological studiesdo notprovideevidence ondifferences in
thecarcinogenicpotentialofinorganicarsenicals. Itispossible
thatthelowersolubilityofarsenictrioxideversuspentoxidemay
favorlongerresidencetimeandcarcinogenicity intherespiratory
pathway. There are no data on the carcinogenicity of arsine
(AsH3). Exposuretoarsineisoccasional, andthehighacutetox-
icity ofarsine limits the possibility ofcarcinogenic exposure.
Thus,0.5 mgAs/m3increasedtheincidenceofcancerafterlong-
termoccupational exposuretoinorganicarsenicsalts(21), while
only afewhoursofexposuretothesameconcentrationofarsine
was severely toxic (13).
Certainepidemiological observations suggestthatarsenicmay
actas acancerpromoterratherthanas aninitiator(34). These
observations indicate that a) though cancer usually develops
after20ormoreyearsofexposure, itcandevelopwithin 10years;
b)effectsofexposuredisappearaftertheterminationofexposure
withtime(18); andc)olderpersonsaremoresensitivetothecar-
cinogeniceffectofarsenicthanyoungerones(17). Thedecline
intheappearanceofnewcasesaftertheterminationofexposure
is in agreement with the decline of arsenic body burden to
backgroundlevelinheavilyexposed Germanwinegrowerswho
died 10 to 15 years after exposure (30).
The interaction between smoking and arsenic exposure has
been the subject of two studies. From the cohort of copper
smelter workers studied by Lee and Fraumeni (16), 150 men
wererandomlyselectedfromtheheavyexposuregroupand 150
fromtherestofthecohort. Reliablesmokingdatawereobtain-
ed from 86% ofthe sample. Between 1932 and 1977, SMRs for
lung cancerwere slightly higher forcigarette smokersthan for
nonsmokers in both groups (35). Among Swedish copper
smelterworkersthecombinedeffectsofsmokingandarsenicex-
posure on lung cancer were morethanadditive(31,36).
Animal Experiments
AnIARC Working Group(11) andaWHO TaskGroup (12)
surveyed the literature published before 1980 and found no
definiteevidence forthecarcinogenicactivity ofinorganic and
organic arsenic compounds in experimental animals. The ma-
jority ofthe studies were negative, and, owing to some weak-
nessesindesign(toosmallnumbers, mixedexposure, inadequate
controls), thepositivestudieswerejudgedinconclusive. Arecur-
rentfindingofmostofthestudiespublishedafter 1980isthein-
creased frequency ofbenignadenomas.
A combination ofperinatal and postnatal treatment ofmice
withtrivalentarsenic (0.5mgAs/kg, SC)increasedtheincidence
oflungadenomas fromthehighbackground levelof18 to63%
(37). Therepeated intraperitoneal administration ofarsenitedid
not increase the incidence oflung adenomas in strain A mice
(38). In8-week-oldSyrianhamsterstheweeklyintratrachealin-
stillationofAs203for 15weeksproduced3lungadenomasin 10
animals given the total dose of 5.25 mg arsenic, and 2 lung
adenomas in 20 hamsters dosed with 3.75 mg/kg. Neither the
treated northecontrol hamsters developed malignancies (39).
Whentheexperiment was repeated with the smallerdose, 3 of
47 (6.4%) hamsters developed respiratory carcinomas (larynx,
trachea, bronchus, orlung)and21 (44.6%)otherrespiratoryle-
sions (adenomas, adenomatoid lesions, and papillomas). The
corresponding numbers were 0 and 7 (13.2%) in 53 controls.
Combined treatment with arsenic and benzo[a]pyrene did not
have a synergistic effect (40). The weekly installation of3.0 g
As/kg as arsenic trisulfideorcalciumarsenate intothetrachea
for 115 weeks induced 1 adenoma in 28 (3.6%) and 4 in 35
hamsters (11.4%), respectively. No adenomas were seen in 26
controls. Theincidencesofadenomatoid lesionswere 12(3.6%),
10(28.6%), and0, respectively. There were nomalignant lung
tumors in any of the groups (41). Arsenic trioxide, arsenic
trisulfide, andcalcium arsenate, given tohamsters atthe same
dosefor2or4weeks, causedtoxic localreactionsmanifestedby
hyperplastic andmetaplasticchangesintheepithelium oftrachea
and bronchi. In calcium arsenate-treated hamsters, there were
also signs ofproliferation, desquamation, anddegeneration of
thebronchiolarepitheliumwithinfiltrationofmacrophages and
lymphocytes (42).
Theseexperimentsindicatethatarsenicistumorigenicandthat
thetumorigenic intratrachealdoseprovokesanacutetoxicreac-
tioninthelung. Theincidenceofrespiratory cancerinonestudy
wasfarbelowthelevelofsignificance, whilethestatisticalpower
ofother studies was too low to allow the detection oflow in-
cidences ofcancer. Asfarastumorigeniceffectisconcerned, the
threeexperiments withidenticaladministrationanddosingshow
thatarsenictrioxide[As(LU)landcalciumarsenate[As(V)] were
morepotentthanarsenictrisulfide[As(ZfI)]andprobablyarsenic
trioxidewasmorepotentthancalciumarsenate. Astheorderof
watersolubilitY is, AS203 > Ca3(AsO4)2 > As2S3, andtheorder
ofretentioninlungafterintracheal instillationisCa3(AsO4)2 >
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As2S3 > As203, tumorigenicpotentialdoesnotseemtocorrelate
either with solubility orpulmonary deposition.
Kinetic Considerations
Solubility isonlyonefactorinpulmonarydepositionafterin-
halation exposure or intrachaeal instillation. Pershagen and
Bjorklund (42) suggested that higher wetting capacity of in-
tratracheally instilled particles contributed to the increased
pulmonary concentrationofcalciumarsenateovertheconcen-
trationofarsenictrioxideorthehardlysolublearsenictrisulfide.
Wetting promotes transport to the alveolar region, where
clearance is slower than from the bronchial region and where
clearance does not increase proportionately withdeposition.
About90%ofdissolvedarsenicand30% ofsuspendedarsenic
trioxide or trisulfide and lead arsenate is absorbed from the
gastrointestinaltract(43). Studiesonhumanvolunteers indicate
thatingestedarsenobetaine isnearly completely absorbedfrom
the gastrointestinal tract and most ofthe absorbed dose is ex-
creted inurine (44).
Thefollowingsummaryonthekineticsofabsorbedarsenicis
compiledfromreviewsfromVahter(43)andMarcusandRispin
(45). Arsenic absorbed from the gastrointestinal tract has a
shorter half-life than inhaled arsenic because it is transported
throughtheportalcirculationdirectlytotheliver, themainsite
ofarsenic biotransformation. Clearance ofarsenic can be af-
fected by two toxic reactions: excess As(II) inhibits its own
methylation to dimethylarsenic acid and the pulmonary clear-
ance ofparticles by alveolar macrophages.
Studiesonrabbitsexposedtoradiolabeledarsenatehaveshown
that dissolved arsenate is rapidly reduced in blood to As(IJ),
thoughsomearsenateisexcretedunchangedinurine. Withtime
there is achangeintheformofarsenic inurine: thepercentage
ofinorganic arsenic declines, and the excretion ofmethylated
forms increases. Inadditiontodimethylarsinic acid, whichisthe
major component, monomethylarsonic acid is present for a
shorterperiodatalowerconcentration. Nodemethylationtakes
place, and trimethylation or the reduction ofdimethylarsonic
acidtovolatiledimethylarsine is not significant. The rapidex-
cretion and low toxicity of dimethylarsinic acid (its LD50 is
350-foldhigherthantheLD50ofarsenictrioxide) isexplained
by its lowaffinity fortissues. Afterthe ingestionofsoluble in-
organicarsenicsalts, theclearencehalf-time inhumansubjects
isabout5days, whileaftertheingestionofdimethylarsenicacid
or arsenic infish, the clearance half-time is about2 to 3 days.
Whentheinhaledarsenicisinsparingly solubleform, reduction
andmethylation isslow, andclearanceisdelayed. Thesefactors
aremostlikelyresponsibleforhighconcentrationsofarsenicin
thelungsofsmelterworkersseveralyearsafterthecessationof
exposure.
The conversion ofAs(V) to As(E) may be one reason why
animalcarcinogenicity studiesdonotdifferentiatebetweenthe
carcinogenicpotentialofthesetwoforms, thoughtoxicitystudies
indicatethatAs(E)ismoretoxicandmorereactivethanAs(V).
As(llI) reacts with sulfhydryl groups, and monosubstituted
arsenite forms stablebondswithtwovicinal sulfhydryl groups
(e.g., inlipoicaciddehydrogediase). Onepossibleconsequence
ofthisreaction istheinhibition DNArepairenzymes. Though
theoxyanionofAs(V) canreplacephosphate in substrates and
can inhibit phosphorylation, the arsenate ester bond is easily
hydrolyzed. AftertreatmentwithAs(V), mostofthearsenic in
thenucleiofcellsisintheformofAs(HI)(46). Thesemetabolic
considerations indicatethatAs(III) ismorelikelytoparticipate
inthecarcinogenic processthanisAs(V). Ithasbeenalso sug-
gestedthatarsenicintakemustexceedthemethylatingcapacity
of the body before any skin lesions (hyperkeratosis or skin
cancer) are produced (43).
Short-Term Tests
Arsenic compounds were consistently inactive in the Ames
Salmonella test with or without the addition of S-9 mix (4).
Arsenite and arsenate were also negative in assays with S.
typhimuriumandwiththetryptophanauxotrophicE. coliWP2
strain (33,47,48). Arsenitedid notinduceXprophage inE. coli
WP2s (49). Thereareconflictingreportsonthemutagenicity of
arsenicintheB. subtilisrecassay,atestwhichisclaimedbysome
to be more sensitive for screening metal carcinogens than
SalmonellaorE. coli(34). Inyeast, botharseniteandarsenate
induced geneconversion (50).
In mammalian cell (gene) mutation assays, arsenate and
arsenitewerenegativeorweaklymutatagenic. Thus, As(HI)was
weaklymutagenic atthethymidinekinaselocus inmouselym-
phomacells (51), anditdidnotinduceouabain-resistantmutants
inChinesehamsterV79cells (49). Arsenicwasnotmutagenic
in the dominant lethal test in mice, though it increased the
mutagenicity ofTepa (tris-l-aziridyl-phosphine oxide) (52).
Pentavalentarsenic inducedmorphological transformationin
Syrianhamsterembryocells(53), andtrivalentenhancedviral
transformationinthesamesystem(54). InC3H/10½hCl8 mouse
embryo cells, As(EII), but not As(V), induced morphological
transformationsbutnotouabain resistance. This indicated that
transformation was not caused by base substitution mutation.
BothAs(E)andAs(V) inducedstableanchorageindependence
indiploidhuman fibroblasts(55). Atlowconcentrations, arsenic
enhancedthecolony-forming efficiencyofSyrianhamsterem-
bryocellsfollowedbydose-dependentinhibitionathighercon-
centrations. As(EI)wasabout 15timesmorepotentthanAs(V).
Thisdifferenceinpotencywasseenalsointheinductionofmor-
phological transformation in Syrianhamsterembryo cells and
theinductionofmethotrexateresistanceinmouse316 cells(56).
Cellular uptake, cytotoxicity, and morphological neoplastic
transformationinthemouseembryocelllineBALB/3Y3clone
A31-1-1 were 4-fold higher for As(E) than for As(V), though
As(V) was converted intracellularly to As(III). The foci trans-
formedbyAsgaverisetotumorigeniccelllines(carcinomas in
nudemice) (57).
Both As(IH) andAs(V) increased polyploidy, chromosomal
aberrations and sister chromatid exchange (SCE) in Syrian
hamsterembryocells inaconcentration-dependent manner, but
arsenite was at least 10 times more potent than arsenate (58).
As(m)wasmorecytotoxicthanAs(V)inDonChinesehamster
cells,buttheinducibilityofSCEwasalmostidenticalattheirme-
dianinhibitorydose(59). Inculturedhumanlymphocytes, on-
lyarsenitecausedSCEs, andarsenitecausedsignificantlymore
gaps andchromatid andchromosomebreaksthandidarsenate
(60,61). Inhumanfibroblasts, morechromosomedamagewas
causedbyAs(IE)thanbyAs(V) (59). Asexcessfrequenciesof
chromosomal aberrations and SCE were observed in the
peripherallymphocytesofexposedhumanbeings,theseinvitro
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Arsenite, butnotarsenate, inhibitedexcision repairinE. coli
WP2, asshownbyenhanced susceptibility tothemutagenicef-
fects ofultraviolet radiation (47). Post-treatment with sodium
arsenite also potentiated the cytotoxicity, clastogenicity, and
mutagenicityofultravioletlight(57)ormethylmethansulfonate
(62) inChinesehamsterovarycells. Whilepost-treatmentwith
arsenite increased, pretreatment decreased the hypoxanthine-
guanine phosphoribosyltransferase mutagenicity of methyl
methansulfonate(62). Arseniteinrelatively lowconcentrations
alsopotentiatedthemutagenicityofN-methyl-N-nitrosourea at
thehprtlocusofV79cells(62). TheinteractionwithUV, methyl
methansulfonate, and N-methyl-N-nitrosurea indicates that
arsenic is a co-mutagen. Arsenic did not affect the fidelity of
DNAsynthesis inacell-freein vitrotest, whileBe, Cd, Cr, Ni,
and Pbdid (64).
Becausearsenic canbemethylatedin vivo, thegenotoxicrole
ofdimethylarsenichasattracted someattention. Inthelungtissue
ofmice, the oral administration of 1.5 g/kg sodium dimethyl-
arsenic acidresulted in DNA single-strand breakswhich were
rapidlyrepaired. Ininvitroexperimentswithlysedanddigested
nuclei, isolated from control mouse lung, strand-breaks were
produced by a reduction product of dimethyl-arsenic acid,
dimethylarsine, butnotbydimethylarsenicacid(65). Asthedose
giventomicewasneartotheLD50ofdimethylarsenic acidand
it delivered 25 times more As(HI) than did the oral LD50 Of
arsenic trioxide (32), this finding has little or no practical
significance for exposure to inorganic arsenic or even to
dimethylarsenic acid.
Thegenotoxicityofinorgaicarsenicwasextensivelyreviewed
by Jacobson-Kram and Montalbano (66), who concluded that
the relativepotencies oftrivalent andpentavalentarsenicals as
sulfhydryl reagents are similar to their relative potencies as
clastogens and SCE-inducing agents.
Conclusions
Contrarytoepidemiological studies, animalexperimentshave
notprovideddefiniteevidenceforthecarcinogenicityofarsenic.
Arsenic is not active in gene mutation tests, but it increases
chomosomal breaks, sister chromatid exchange, and mor-
phologicaltransformationinmammaliancells. Leonard(52)in-
terpretedthepositiveclastogenic andnegativemutageniceffects
asanindicationofco-carcinogenicity mediatedthrough inhibi-
tionofrepair. Thereissomeepidemiologicalevidencetosupport
theview thatarsenic morelikely acts as apromoter and not an
initiator. In vitro tests indicate that arsenite is a more potent
genotoxic agentthanarsenateandarsenate actsonly after con-
version to arsenite and thatthe activeagent isprobablyAs3+.
Beryllium
Epidemiology
Berylliumcancauseskinlesions, acuterepiratory inflamma-
tion, and progressive interstitial pulmonary granulomatosis,
knownaschronicberylliumdisease. Whileacuterespiratory in-
flammation, areversibleillness, ismainlytheresultofhighex-
posuretosolubleberylliumsalts,chronicberylliosisistheresult
of prolonged exposure to mostly insoluble beryllium com-
pounds. Thecollectionofcasereportsregisteredfrom 1952on-
ward in the Beryllium Case Registry at the Massachusetts
General Hospital and cohort studies were the basis for several
overlappingepidemiologicalreportsonthecarcinogenic effect
ofberyllium. Theseepidemiological studieshavebeenextensive-
ly reviewed (2,7,67-69).
These studies showed a consistent pattern of elevated age-
standardized observed-to-expected ratios of 1.3 to 1.6 for lung
cancerinworkersexposedtoberylliumforlessthan5 years, with
the highest ratio in the 3 to 15 month exposure group. Lung
cancershowedelevatedratiosonlyamongworkerswhohadex-
perienced acute berylliosis, but not in workers with chronic
berylliosis. Thedifferencecanbeexplainedbythefactthatacute
berylliosis is always a sign of toxic exposure, while chronic
berylliosis isahypersensitivity reaction. Increasedcancerdeath
occurred after 15 years oftheonsetofBe exposure.
Criticsoftheseepidemiologicalstudiespointedouta)thein-
fluenceofoverlappingcasesontheconvergenceoftheresultsof
several studies; b) the lack ofdose-response or length ofex-
posure-incidence correlation; c) the lack ofconsideration for
possibleconfoundersincludingsmokinghistoryevenwhenitwas
available;d)manipulativeuseofinputdataincludingunjustifiable
lowcontrollungcancermortality;e)inclusionofalungcancervic-
timwhodidnotsatisfytheconditionforinclusion;andJ)lackof
adequatecontrolgroupselection(7,68). Aco-authorofareport
publiclydisownedthecontentbecause thepaper failed to men-
tionthat42ofthe47lungcancerdeathcasessmokedcigarettes,
and 1 oftheremaining5 casesdiedfromcausesotherthanlung
cancer. After adjusting for cigarette smoking, the significant
elevation oflung cancermortality disappeared (7).
These revelations naturally affected the acceptance of the
epidemiological evidence more in the United States than else-
where. Thus beryllium is considered to be an established car-
cinogenintheworkingenvironmentinSwedenandintheFederal
Republic ofGermany (2), while the International Agency for
Research on Cancer (IARC) (11) classified the human epi-
demiological evidence as limited, and EPA (7) classified it as
inadequate.
AnimalExperiments
GardnerandHeslington(70) observed osteosarcomaineach
ofninerabbitsinjectedintravenouslywithzincberylliumsilicate.
Since the publication of this report experiments on the car-
cinogenic potential ofberyllium have covered every possible
routeofadministrationandseveralberylliumspecies fromsolu-
ble beryllium compounds to alloys. Several short reviews
(2,4,68)andacomprehensiveevaluationbyEPA(7)summarize
the conclusions of these studies. The review by EPA, which
tabulates dataseparatelyforeachrouteofadministration, isthe
main sourceofthe following summary.
Experiments demonstrated that the IV injection of zinc
berylliumsilicateinrabbits, butnotinratsandguineapigs,pro-
duces consistently metastasizing osteosarcomas in the long
bones. Similar results were obtained with beryllium oxide,
beryllium phosphate, and beryllium metal or by injecting
berylliumintothemedullarycavityofbones. Nootherrouteof
administrationledtotheformationofosteosarcomas. Splenec-
tomy increased carcinogenicity. The tumors were chon-
droblastic, osteoblastic, orfibroblasite (7).L. MAGOS
The repeated intratracheal instillation of beryllium metal,
berylliumoxide, berylliumhydroxide, andberyllium-aluminum
alloywith62% berylliumcausedpulmonarycarcinomas inrats
andmonkeys. Alloyswithlow(4% orless)berylliumconcentra-
tions were ineffective. Firing temperature affected the car-
cinogenicpotencyofBeO. Cancerincidencewasminimalafter
theinstillationofhigh-fired(1600°C)ormedium-fired(1100°C)
BeO andhighafter the instillation oflow-fired (500°C) BeO.
Inhalation exposure of rats to beryllium sulfate, beryllium
phosphate, beryllium fluoride, zinc beryllium manganese
silicate, berylore, butnotbertranditeore, werealsocarcinogenic
in rats. Rhesus monkeys wereless sensitive, and rabbits, ham-
sters, andguineapigs seemed, inmoststudies, tobe resistant.
Thus, exposurethatgave 100% carcinogenicity inrats wasinef-
feciveinguineapigs. Ona35hrweekexposureschedule, 10ltg
Be/m3 (as BeSO4) was the threshold for the induction of
pulmonaryadenocarcinomainrats(68). Mostofthemalignan-
cieswereadenocarcinomas withapredominantlyalveolarpat-
tern. ASovietstudyreportedadose-dependent increase inthe
incidence oflung carcinomas in rats exposed to BeCl2 or BeO
concentrationsrangingfrom0.8to400jigBe/i3for 1 hr/day, 5
days/week, for4months. Thelungtumors weresquamouscell
carcinomas, adenocarcinomas, andundifferentiatedcarcinomas
(71).
Neoplasmas werenotobservedafterintracutaneous injection
orpercutaneous applications andthere is noexperimental evi-
dencethattheoraladministrationofberyllium iscarcinogenic.
Inthelungadenomaassay, BeSO4wasweaklypositiveinstrain
A mice (72).
Kinetic Considerations
Berylliumisanamphotericelementandthereforeitisableto
formpositiveornegativeionsinacidicorbasicmedia, whereas
inthebufferedenvironmentoftissues,berylliumsaltsarereadily
precipitatedascolloidalberylliumphosphate/berylliumhydrox-
idecomplexes. Theprecipitationofberyllium saltsinbloodafter
IVinjectionleadstoretentionmainlyinthereticoloendothelial
systemandbone. Theremovalofspleen, thisimportantstorage
organ, increasedthecarcinogenicityofIV-injectedberylliumin
bones, mostlikelybyallowingtheretentionofahigherpropor-
tionofthedose inthistarget (7,73).
Afteringestion, about20% ofthedose isabsorbedfromthe
acidic stomach while the remaining part of the dose is pre-
cipitated in the gut to an insoluble form (68). Pulmonary
clearance is multiphasic; a fast clearance rate is followed by
rapidlydiminishingeliminationrate. Afterprolongedinhalation
exposuretoBeSO4, pulmonaryclearancehalf-timewasapprox-
imately2weeksandthereafterdiminishedrapidly. Thoughsolu-
bleberyllium salts alsoprecipitate out inthe respiratory tract,
theirinitialclearanceisfasterthantheclearanceofinsolubleor
sparingly soluble forms (68).
Uptakebycellsismainlybyendocytosis(thephagocytosisof
solidsandthepinocytosisofliquiddroplets)andclearanceisby
macrophagesandbythemucociliaryescalator. Whenalveolar
macrophagesaredamagedbytheengulfedberyllium, lysosomal
enzymesarereleasedandclearanceissloweddowntemporari-
ly. After this initial periodofinhibitionsphagocytic activity is
stimulatedby beryllium(72,74). Aftera single 1-hr inhalation
exposure of rats to 4 mg Be/m3 (as BeSO4), the signs of cell
deathsandincreasedphagocyticactivity inthebronchoalveolar
lavagepersisted atleast for 1 year (75).
The presence ofberyllium in lysosomes is only temporary.
Theacidicmilieuoflysosomesisfavorabletothedissolutionand
dissociation ofberyllium compounds to ionic beryllium. The
cytotoxicpotentialincreaseswithdissociability andthatiswhy
colloidalberylliumhydroxideismorecytotoxicthanparticulate
berylliumphosphate, andmoreBeOthanBeSO4is requiredto
damage macrophages(74,76,77). In surviving cells (e.g., lung
tissue) there is a gradual transfer ofberyllium to the nucleus,
where beryllium is associated mainly with highly phos-
phorylated nonhistone proteins with consequent interference
with the phosphorylation ofnuclear proteins andcell division
(72). As beryllium ions are released from the surface ofpar-
ticles, the conversion ofmass to surface concentration (area/
volumeofmedium)resultedinsimilarexpressionofcytotoxicity
bythedifferentphysicalformsofthesameberylliumcompound
(78).
Thedamagetomacrophagesbyincorporatedberylliumleads
to greater infiltration by macrophages and lymphocytes and
ultimately to the formation of immunological granuloma-a
hypersensitivity reaction. Thiscondition, whichwasthecause
of the highest beryllium-related mortality among exposed
workers, was caused mainly by high-fired beryllium oxide,
whereasacutepulmonarydiseasewascausedbyhighexposure
tosolubleberylliumcompounds. Besidestheexclusionofhigh-
andandmedium-firedberylliumoxides, no similarcategoriza-
tionispossibleforthecarcinogenicpotentialofdifferentforms
ofberyllium. Apointofinterestisthatguineapigsdonotreadily
respond withtumors toberyllium exposurebut show granulo-
matous dermalhypersensitivity, whichcanbepreventedby in-
halationexposuretoberylliumsulfate. Thisseemstoindicatethat
beryllium-induced granulomatous hypersensitivity and car-
cinogenicity aremutually inhibitory processes (68,73,74).
Short-Term Tests
Theselectionofberylliumspeciesforshort-termtestshasbeen
dictatednotbytheirimportnceinhuman exposure, butbytheir
solubility. Thus, in a table on the activity ofberyllium com-
pounds in in vitro assays, Baker (9) listed one entry for an
unspecifiedform, sevenentries forBeSO4, andfiveforBeC12.
Beryllium was not mutagenic in plate incorporation assays
withSalmonellastrains(Z69,72). Nevertheless, inthefluctua-
tion assay, BeS04 was mutagenic to Salmonella TA100 (but
negative to other strains) and to E. coli (48). Both amber and
ochre mutations were inducedby BeC12 in the lad gene ofE.
coli, primarily involving base substitution (79). BeS04 was
weaklypositiveintherecassaywithBacillussubtilis, anditwas
negativeinthefollowing:polassay (whichmeasuresthegrowth-
inhibitingpropertiesofmutagenicagentsinrepairproficientand
deficientstrains)ofE. coli; host-mediatedassay; mitoticrecom-
bination assay in yeast; and DNA repair assay in hepatocyte
primary culture (7).
Theinductionof8-azaguanine-resistantmutantsbyBeCl2in
Chinese hamster V79 cells and by BeSO4 in Chinese hamster
ovary (CHO)cellshasdemonstratedtheabilityofberylliumto
cause gene mutations in cultured mammalian cells (7). In
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Chinese hamster lung cells, BeSO4 caused no chromatid or
chromosomal aberrations (72), but it produced chromosomal
breaks andSCEinculturedhumanlymphocytes, Syrianhamster
embryo cells (80), and CHO cells. Chromosomal damage in
CHOcellswasmorethanadditivewhencellsweretreatedwith
beryllium sulfate and X-rays (81).
BeCl2decreasedthefidelityofDnAsynthesisinthepresence
ofpoly[d(A-T)] templateinacell-freein vitro system, probably
by the interaction ofBe2+ withDNApolymerase (64). Similar
results wereobtained with other systems (72).
Conclusions
Animal experiments have supplied sufficientevidenceforthe
carcinogenicity ofberylliumanditscompoundsadministeredby
routes relevant to human exposure. These experiments also
demonstrated wide species differences inthecarcinogenicity of
beryllium, ratsbeing themostsensitiveandguineapigsthemost
resistant. The inadequacy ofepidemiological evidence for the
human carcinogenicity ofberyllium indicates thathuman sen-
sitivity mustbewell belowthesensitivity ofrats. Inthepre-1950
period, the atmospheric beryllium concentration of several
workplaces in beryllium production plants was around 1000
j&g/m3 (68), while the median effective concentration of
beryllium sulfate for the induction ofpulmonary carcinoma in
rats (weekly 35-hr exposure for 3 or more months) was 18 tg
Be/m3 (7).
The exclusive use ofhighly soluble beryllium compounds in
short-term tests limits extrapolation toother forms, but, inagree-
ment with animal experiments, these assays indicate that
dissociation to Be2+ is akey step in the carcinogenic process.
Cadmium
Epidemiology
Apossibleassociationbetweenexppsure to CdO and cancer
was first raised inthe United Kingdomby thedeathcertificates
ofeight Ni-Cdbattery workers with 14 to 38 years ofexposure
to cadmium. Five oftheeight workers died ofcancer, three of
them from prostatic cancer (82). This finding initiated the
epidemiological surveyof248 workerswithatleast 1 yearofex-
posure. Theidentificationofoneadditional prostatic cancer case
resulted in a 4/0.58 observed/expected (O/E) mortality ratio,
while theO/Eratio was 5.0/4.4 for lungcancer (83). The resul-
tantepidemiological studies, fromtheUnitedKingdom, United
States, and Sweden, covered notonly Ni-Cdbattery plantsbut
alsoCdsmeltersandtheproductionofCdcompoundsandalloys.
These studies were the subjects ofseveral reviews (2,84-87).
Theoutcomeoftheseepidemiological studieswascontrover-
sial. Thus, in 1985 Elinderetal. (88)argued thatepidemiolog-
ical studies "support an association between lung cancer and
cancer of the prostate and the exposure to cadmium" while
Kazantzis andLan (89)arguedthattheassociationwas notvalid
forprostatic cancerandinconclusive forlung cancer. Thesecon-
flicting views reflected disagreement over thejudicious use of
mortality data(forprostaticcancer) andthe roleofconfounding
factors (lung cancer).
According to Doll (6,90), when an unexpected finding is
observedandotherstudies aremadetocheckit, thehypothesis-
formingdatamustbeexcludedfromsubsequentanalysis. Inthe
samenickel-cadmiumbatteryfactory, wherethefirstfourcases
ofprostaticcanceroccurred, thefollow-upof2559malenickel-
cadmiumbatteryworkersfoundfouradditionaldeathsfrompro-
staticcancerduringtheperiodof1946-1981. Thenewcaseswith
the four old cases gave a 8/6.6 O/E ratio and without the
hypothesis-forming cases the SMR declined below below 100
(91). Theconditionofinclusioninthisstudywasstartofemploy-
mentbetween 1923and 1975andatleast 1 monthofemployment.
Whenthecohortwasdecreasedto458workerswithaminimum
employmentof1 yearandajobinvolvinghighexposuretocad-
mium (negative active material, assembly, plate making), the
O/Eratioforprostaticcancerincidencebecame8/1.99withand
4/1.78 withoutthehypothesis-generating fourcases. The4/1.78
fornew cases was not significant (92).
In a Swedish Ni-Cd battery plant, a study found 2/1.2 O/E
ratio for prostatic cancer (93). The extension of this study
resulted in 4/2.4 and 4/2.7 O/E ratios (94). In a Swedish cad-
mium alloy factor four workers died ofprostate cancer versus
2.69 expected (93).
Lessthanexpectedprostaticcancerdeathswerefoundamong
331 cadmium-copper alloy workers exposed toamean level of
70ygCd/m3. Invicinityworkers, whohadbeenexposedtoon-
ly6 ± 8 (SD)1g/m3Cd, theobserved-to-expected ratioofpro-
static cancer mortality was 8/3 (95). Vicinity workers were
engaged in the manufacture ofarsenicals and copper and had
more than 10 times lower cadmium exposure than cadmiu-
copperalloyworkers. Basedonthelowlevelofexposureandthe
presenceofconfoundingexposure, itseemsclearly unjustified
to use, as Elinder et al. did (94), the 8/3 O/E ratio ofvicinity
workersor9/4.7ratioofthecombinedgroupsofcadmiumalloy
andvicinity workerstosupporttheetiological roleofcadmium.
ArmstrongandKazantzis (96) includedintheirstudyallmajor
plants in England in which processes involving cadmium had
beencarriedout. Theexceptions werethenickel-cadmiumbat-
teryfactoryandthecoppercadmiumalloyplantdescribedabove.
Themortality experienceof6995 workersbornbefore 1940and
exposedtocadmium formorethan 1 yearbetween 1942and 1970
was followed up to 1979. O/E ratio for prostatic cancer was
23/23.3 inthewholegroupand0/2.9 inthe "everhigh" (3%) and
"ever medium" (17%) exposure groups (96). A 5-yearupdate
foundtheratios 30/33.2 forthetotalpopulationand0/4.6forthe
high and medium exposure groups (97).
The firststudy inaCd-smelterintheU.S. seemedtoconfirm
the role ofcadmium inprostatic cancer. The vital status of292
cadmiumproduction workerswithatleast2yearsofemployment
was recorded from the first day of 1940 to the last day of 1969.
Employmentyearsweregivenonly forcasesofprostatic cancer
deathandwithoutstatingwhetheremploymentwascontinuous
orintermittent, orwhether itstartedbelbre 1926, whentheplant
operated as anarsenic smelter, orlater. Therewerefourprostatic
cancerdeaths, whichoccurred25 to 32yearsafterfirstemploy-
ment, versus 1.15 expected(98). Anextensionofthisstudy to602
workers withatleast6months ofexposure found no newdeaths
fromprostatic cancer. Moreover, whentheclassification ofthe
cohort required notonly 2 years minimumemployment, but at
least6months ofexposure, oneprostatic cancer casehad to be
removed, and the original 4/1.15 O/E ratio (SMR = 347) was
reduced to 3/2.2(99).
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Thus, epidemiological studies failedtosupporttheroleofcad-
mium in thecausation ofprostatic cancer. WhenO/E ratios of
lastfollow-ups aresummedupwiththeO/Eofcadmium-copper
alloy workers, the result is an insignificant 16/13.8 and not the
significant28/17.2 ascalculated by Elinderetal. (94). Theoc-
cupational data are supported by thecomparison oflatent and
fatalprostaticcancersinJapaneselivinginHawaiiandJapan. La-
tent prostatic carcinoma is equally common in the two com-
munities, butinspiteofsignificantlyhigherdietaryintakeofCd
inJapan, themortality from cancerofthe prostate is higher in
Hawaii (100).
Contrary toprostatic cancer, epidemniological studies, withthe
exceptionofone(95), consistently showedincreasedlungcancer
SMRs. Theexcesseswerenotalwayssignificantandnotalways
increased with exposure.
In the cohort of 2559 male Ni-Cd battery workers, an in-
significantincreaseofprostaticcancermortality wasassociated
withaslightbutsignificantincreaseoflungcancer. Therewere
87casesofrespiratory cancerdeathsversus68expected(SMR
= 128). Exposure to cadmium ranged from 0.6 to 2.8 mg/m3
before 1950, declinedto < 0.5mg/n3after 1950, to < 0.2mg/m3
after 1967, andtoandbelow0.05mg/i3after 1975. Possiblecon-
founding factors associated with workwerewelding with oxy-
acetylene and exposure to nickel hydroxide (91).
In a follow-up, the mortality experience of 3025 workers
employedbythesamebatteryplantintheperiodof1923 to 1975
wasanalyzed (101). Theestimatedcadmiumexposure (duration
ofemployment) ofthose who had died in theperiodof 1946 to
1984fromlungcancerwascomparedwiththeexposureofthose
whosurvivedthesameyearandstartedemploymentatthesame
ageand sameyear. Amongworkersfirstemployedintheperiod
of 1923 to 1946, there was someevidenceofan associationbe-
tweentheriskofdyingfromlungcanceranddurationofemploy-
mentinhigh-andmoderate-exposurejobs,althoughtheevidence
relied heavily on the findings for the single highest exposure
(morethan 15yearsemployment) category. Amongworkers first
employedintheperiodof1947to 1975, therewasnoevidenceof
such an association (101).
InaSwedishNi-Cdbatteryfactoryinagroupof228workers,
2diedoflungcancerversus 1.35expectedbetween 1959and 1975
(93). In anextended study, 522 workers were included. There
were 8 deaths from lung cancer versus 4.1 expected (SMR =
133)between 1951 and 1983. Allhadatleast 5yearsofexposure,
and with oneexception alldied atleast20years aftertheonset
ofexposure. Mostofthose workers whodeveloped cancerhad
startedtoworkbetween 1948and 1960when, owingtoheavyex-
posure, 46% oftheworkershadproteinuriacomparedwith9%
after 1963. Thus, thelevelofcadmiumexposurewas 1mgCd/in3
before 1947,about0.3 mg/m3in 1947to 1962,0.05mg/m3in 1962
to 1974, and0.02 mg/m3after 1975. Exposuretonickelhydrox-
idewasusually 2 to 10timeshigherthanexposure tocadmium
(94).
InthestudyofArmstrongandKazantzis(96), whichincluded
6995workersexposedtocadmiumformorethan 1 yearbetween
1942 and 1970, there was a marginal excess (199 vs. 185.5,
SMR = 107) of lung cancer mortality. This excess occurred
mainlyinthe"alwayslowexposuregroup" andwasabsentinthe
"always high exposure" group. A 5-year update ofthis study
foundtheSMRforlungcancerrisingfrom 107tothesignificant
(277/240.9) 115 level. SMRwasthehighestinthevery small (12
observed, 6.2 expected) "ever high" exposure group. SMR
showed apositive, though not significant, correlationwith ex-
posure. Analysis ofmortality pattern showed that lung cancer
risk increased when employment exceeded 20 years, started
before 1940, and the follow-up period was long. Work in the
lead-zinc-cadmium smelter, and to alesser extentin copper-
cadmium alloy manufacture increasedrisk(97,102).
Anonferrous smelterwasthesubjectofamoredetailedstudy
(103). In a cohort of4393 men, the SMR for lung cancer was
124.5 with 182/146.2 O/E ratio. SMR increased with years of
employment, but the increasing risk of lung cancer was not
restrictedtoaparticularprocessordepartmentandcouldnotbe
accountedforbycadmium. Associationbetweenmortality and
gradedexposuretoseveralenvironmentalcontminants wasex-
aminedwithmatchedlogistic regression. Relativeriskdid not
increase with increasing exposure to cadmium, zinc, SO2, or
dust, but it increased with increasing exposure to arsenic and
lead.
Inthemortalitystudyof292UnitedStatescadmiumproduc-
tion workers (98), there were 12 observed respiratory cancer
deathsversus5.11 expected. Tenofthetwelverespiratorycancer
deathsoccurredatleast 15yearsafterfirstemployment(94). An
extensionofthisstudyto602 workerswithatleast6monthsof
exposureconfirmedincreasedmortalityfromrespiratorycancer.
Therespiratorycancermortalityratiowas3/0.56forthosewho
werehiredbefore 1926and 15/7 forthosehiredlater(99). Before
1950, intheproductiondepartments,exposuretoatmosphericCd
was generally slightly greater than 1.0 mg/m3 with occasional
valuesover 10mg/m3 After 1950,exposuregraduallydecreased
to0.6mg/m3andbelow0.2mg/m3inotherdepartments. Based
on very low (- 1 g/rM3) arsenic concentrations measured in
1973 intwoatmosphericsamplesfromthepremeldandonesam-
plefromtheretortdepartment, thefirstreport(98)rejectedthe
roleofarsenicasapossibleconfoundingfactor. Contarytothese
threelowvalues, arsenicconcentrationsatroastingandcalcine
furnaces were 300to700 &g/m3 in 1950and 100Ag/m3 in 1979
(99).
The discrepancy between different epidemiological studies
maybeattributabletodifferencesincadmiumexposure. Thus,
intheUnitedStates, cadmiumproductionplantworkerswereex-
posed to 100 to 1500 I&g Cd/m3 before 1960 (95), while the
average exposure of smelter workers studied in the United
Kingdom wasonly 60lg/m3(93). IntheUnitedKingdom Ni-
Cdbatteryplant, increasedincidenceoflungcancerwasfound
only in workers employed before 1947 but not later (101).
Anotherexplanation isthepresenceofconfounding variables:
Thus, inthesecondreportonUnitedStatescadmiumproduction
workers, it was assumed that arsenic exposure should have
resultedinnotmorethan0.77lungcancercases(99). However
this value was based on the following assumptions: a) atmo-
sphericconcentrations neasuredin 1950orlaterwererepresen-
tativeofconcentrations between 1926and 1950; b) respirators
were wom according to regulations and the use ofrespirators
decreasedexposureby75%;andc)only30% oftheworkingday
wasspentinhigh-exposureareas. Theseassumptionsmayhave
introducedasubstantialerrorintheanalysisevenwithoutanad-
ditionalproblemcausedbytheidentityofareas(likeroasdngand
calcinefurnaces)withhighcadmiumandarsenicconcentrations.
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Epidemiological studies oncadmium-exposedworkershave
notgiven information onthecontributionofsmoking tothe in-
ductionoflung canceranddid notdifferentiatebetweenthedif-
ferent chemical and physical forms of cadmium. The lack of
smoking dataisalways a cause for concern, buttheproblem is
amplifiedwhenthetargetisthelungandthereis aconcomitant
exposure toarsenic. Thus, in aSwedish copper smelterthe age-
standardizedratiofordeathfromlung cancer was3.6forarsenic-
exposednonsmokers, 4.9forsmokerswithoutarsenic exposure,
and 14.6 forarsenic-exposed smokers (36). Themultiplicative
effect of smoking and arsenic exposure on lung cancer death
presents alogisticproblemfortheselectionofmatchingcontrols.
Animal Experiments
Inthe firstexperiments on thecarcinogenic potential ofcad-
mium, the route ofadministration was either intramuscular or
subcutaneous. The injection of suspensions of 25 mg finely
dividedcadmium, cadmiumsulfide oroxideregularly gaverise
to rhabdomyosarcomas or fibrosarcomas in rats. The tumors
weremetastatizingandpleomorphicwithhighyield(2). Itiswell
known that the injection of cadmium at this dose level has a
necroticeffectatthesiteofinjectionsandnecrosis mayhave con-
tributedtothedevelopmentofnonmetastasizing testiculartumors
in rats and micetreated subcutaneously with soluble cadmium
salts(chloride orsulfate). Thus, theweeklySCinjectionof86.5
Agcadmium asCdSO4for2 years(approximatetotaldose = 25
mg/kg) produced notesticular,orprostatic changes (104). The
same cadmium compound given in single IM dose of3.4 mg
Cd/kg regularly led tothedevelopmentofprostatic adenomas.
The samedosegiven subcutaneously inducedtesticularinstead
ofprostaticadenomas(105). Theinductionoflocal sarcomasand
testicular tumors was prevented by the administration ofzinc
acetate (2). The interaction ofzinc withcadmiumis acomplex
phenomenon. Zinc acetate in adoseof 1 mmole/kgchangedthe
targetofSCCdCl2fromthetestis totheprostate, butitdecreased
theincidenceofprostaticadenomas from42% to25% afterthe
IMadministrationofcadmium (105). Carcinomas intheprostate
wereproducedin ratsonlyrarely when 1.2 mg Cd/kg asCdCl2
was injected into the ventral prostate (106).
No carcinogenic responses were observed in seven studies
(five on ratsandtwo onmice) as aresultoflifetime exposure to
cadmium in drinking water or food or by gavage. There is no
evidencethatcadmiumiscarcinogenicbythedermal route(107).
Inhalationexperimentswithcadmiumaerosolsindicatedthat
cadmium is notcarcinogenic in the hamster orthe mouse. Ex-
posuretime was 19hr/day, 5days/week, and exposurelastedfor
18 months, followed by a 6- to 12-month observation period.
Concentrations ranged from30to90jgCd/m3 forCdCl2, 10to
270Ug/M3forCdO, and30to 1000 Lg/m3forCdS. Somegroups
wereexposed8hr/day. Tumorincidence waslowinhamstersand
high inmice, butinbothspecies noexposure-related tumorin-
cidencesoccurred. Thus, thepercentageoftumor-bearingmice
in the exposed groups varied between 2.6 and 35.6%, while in
control groupsbetween 14.6and36.9%. Tumortypes were not
described (108).
Rats wereexposed toatmospheric cadmium 22 to23 hr/day,
7days/week, for 18months, andsurviving rats wereobserved for
afurther 13-monthperiod (109-113). Carcinogenicity and mor-
tality data aresummarized inTable 1. As no sexdifference was
seen, dataformales andfemales aregroupedtogether. Table 1
indicates thatCdOfume waslesscarcinogenicthanCdOdust or
CdCl2, CdSO4, or CdS. Solubility did not influence car-
cinogenicity. Owing tohighmortality, the 18-month scheduled
exposureperiodhadtobeterminatedearlierfor somegroups ex-
posedto90 or270 MgCd/i3. Forcontinuouslyexposedrats,the
lowestlevelofexposurethatincreasedmortality wasaround50
Mg/i3, and 90 tg/m3 waslethal to asignificantproportionofthe
exposed group(109,110). Exposure toCdCl2 orCdOdustat30
Ig/m3 Cd concentration induced lung tumors in about 75% of
rats, and a high proportion of tumors were malignant. In a
separatestudy, 6of40rats(15.4%)exposedto 12.5isgCd/m3, in
the formofCdCl2developedprimary lung carcinomas (111).
Gross necropsyofdeadanimalsshowedthat exposure tocad-
miumaerosolincreasedlungweightandenlargedthoraciclymph
nodes. Cytometric analysis of bronchoalveolar lavage and
pulmonary histology showedthat exposure to301g/m3caused
significant inflammation, progressive interstitial fibrosis, and
brochiolo-alveolarhyperplasia(112). Adenocarcinoma was the
most commonlung tumor, followedbyadenomaand squamous
cellcarcinoma(113). Exposureto 10 MAgCd/m3(asCdO)neither
induced tumors nor increased cell debris in bronchoalveolar
lavage. Zinc aerosol in a 10 to 1 Zn/Cd ratio prevented the
tumorigenicity ofCdOinthe30 MgCd/n3 exposure groupand
reducedthetumorigenicityof90 MgCd/m3(107). Treatmentwith
zinc reducedmortality to thecontrollevelinboth groups(109).
When exposuretime wasreducedto40hrperweekandtheex-
posureperiodto6months, pulmonary cancerdevelopedonlyin
2.5% ofratsexposedto270 zgCd/m3asCdSandin 17.5% ofrats
exposedto90 zgCd/i3 asCdOdust. Mortality was0and2.5%,
respectively (109,110,112). Asdaily exposuretimeandduration
ofexposure weredecreasedtogether, itisimpossibleto propor-
tionresponsibility forthedecreaseincarcinogenicity ormortali-
ty. Nevertheless, theoutcomeofexperiments withstandardand
reduced exposures suggeststhatthe carcinogenic exposurelevel
justlaggedbehindtheleveloflethal exposureand waswithinthe
level thatcaused inflammatory reactions.
In a testofthepulmonarytoxicity ofcontinuous exposure to
100 Mg Cd/m3 as CdO, the same research team found definite
ibble1.Thenortali andcarcinoenicityofcontinuous expxsue (22br/day,
7days/week) todifferentcadmium compounds inWistar rats.'
Cdconcen- % ofrats
tration, Exposure, 24-Month Withlung With lung
Compound Ag/m3 months mortality tumors malignancies
Control 7.5 0 0
CdCl2 30 18 0 73.6 57.9
CdSo4 90 14,18 57.5 72.5 57.5
CdS 90 18 12.5 80.0 70.0
CdS 270 16 32.5 79.0 73.6
CdOdust 30 18 5.0 75.0 57.5
CdOdust 90 7,11 35.0 60.6 48.4
CdOfume 10 18 0 0 0
CdOfume 30 18 0 19.4 5.5
'Eachgroupconsistedof20maleand20femalerats(109,110). Theplanned
exposure period was 18 months, but exposure was terminated when mortality
reached the 25% level. When exposure periods were different for males and
females, thefirstofthetwonumbersgivesmonthsofexposureformalesandthe
second forfemales.
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signs of alveolar inflammation and cytotoxicity in the bron-
choalveolarlavageafter 1 monthofexposure (112). Theweekly
exposure inthis experiment was 15.2 mg Cd/m3-hr. Somewhat
higherweekly exposure toCdO (24 mg Cd/m3-hr), but a more
intermittent type (1.6mg Cd/in3, 3hr/day, 5days/week) resulted
insimilarabnormalities. Thesepeaked onthesecondweekand
declined afterwards (114). After 1 month of exposure, the
bronchoalveolarlavageofintermittentlyexposed rats was nearer
to control values thanthelavage ofcontinuously exposed rats.
Thoughhamstersandmice wereresistanttothecarcinogeni-
cityofcadmiumaerosols, exposureresulted indose-dependent
toxic responses in the lungs. The most common sign was
bronchiolar-alveolar hyperplasia. Mean lifetimedecreased in
bothspecies(108). ThelungofSyriangoldenhamstersexposed
8 hr/day, 5 days/week, to 90 1tg Cd/m3 as CO for 65 weeks
showed a significant increase in the volume density of pro-
liferative areas. Thedamagepersistedat48weeksaftertheend
ofexposure. CdSproducedthe samelesionswhen exposure was
increased to270,gCd/i3. Solublecadmiumcompounds were
testedwith adaily 19-hr exposureto30lsgCd/m3for65 weeks.
CdCl3 was noteffective, andCdSO4causedonly slightincrease
inlung lesions in femalehamsters (115).
Though there were no noticeable differences between the
carcinogeniceffectsofdifferentcadmiumcompoundsinthelung
(110), itis mostlikelythatprostatic cancer canbeinducedonly
by soluble cadmium compounds administered by routes ir-
relevanttohumanexposure. Thus, evenchangingtheadministra-
tion from intramuscular tosubcutaneous abolishedtheabilityof
CdCl2 to induce prostatic cancer (105), probably because the
delivery of Cd2 was slower. An additional problem for the
extrapolation of prostatic neoplasms induced in rats by in-
tramuscular cadmium to exposure routes relevant to human
exposureistheconsiderabledifferencebetweentherodentand
the human prostate.
The solubility of cadmium compounds was not a decisive
determinant of inhalation toxicity. At 90 tg/m3, CdS was less
toxic than CdO dust, and the toxicity of the soluble CdSO4
was between the toxicities ofthese poorly soluble compounds
(109). Other studies found the soluble CdCl2 and the poorly
soluble CdO either equally toxic (83) or CdO more toxic to
the lung than CdCl2 (112,116,117). Both the mortality of rats
(109) and pulmonary toxicity in hamsters (115) indicated that,
in agreement with its higher bioavailability (112), CdO is more
toxic than CdS.
A point of interest is the association between the carcino-
genicity and the irritative-corrosive effect of cadmium. Ex-
perimentaldataindicatethatwhilecarcinogenicity isalwaysthe
result of treatment with an irritative-corrosive dose, the ad-
ministrationofsuch adoseisnottheonlyconditionofcadmium-
inducedcarcinogenesis. Thus, hamstersandmicerespondtotox-
iccadmiumexposurewithlungdamagebutnotcancer. Evenin
rats, pulmonarydamagedoes notnecessarily leadstotumorin-
duction. One orthree intratracheal instillations of25 jsg Cd as
CdOcausedpulmonaryedemainrats,butnotumors(133). This
seems to indicatethatthecontinuous contactofthepulmonary
tissueswithcadmium(assuredbycontinuousexposure)is more
importantfortheinductionofpylmonary cancer thantheshort-
term presence ofanacutelytoxicdose.
Kinetic Considerations
Theabsorptionofingestedcadmiumranges from 1 to 7% in
different species, and it ranged from 4.7 and 7.0% in human
volunteers. Cadmium in the inhaled air is in the form of an
aerosolanditsdepositiondependsonparticlesize. Inhumans,
25to50% ofcadmiumincigarettesmokeisretained(119). Inthe
inhalationexperimentsdescribedabove, ratsinhaledparticlesof
0.3to0.5Amdiameter. Thesearepredominantlydepositedinthe
alveolarregion, the siteofobserved tumorformation. Assum-
ingthatinindustrialexposurethemedianaerodynamicdiameter
ofCdO particles is about 2 to 3 zm, deposition must be pre-
dominantly in the conducting airway and the origin oftumors
bronchogenic. Limitedepidemiological evidenceindicatesthat
this isthe case (85,120).
Occupational data indicate that the pulmonary retention of
CdSislowerthanthatofCdOofsimilarparticlesize(119). After
1 monthofnearlycontinuousexposureofratsto 100AgCd/m3
asCdOorCdCl2or 1000AgCd/m3asCdS, thepulmonarycad-
mium was 27, 48, and 138gig, respectively. During a 2-month
post-exposureperiod, thepulmonaryclearancehalf-time (2 to
2.5 months) slowed negligible differences between exposure
groups. Cadmium inthecytosolic fractiondeclined inpropor-
tionofthetotalpulmonary load. Withinthisfractiontherewas
anabsoluteincreaseincadmiumboundtometallothionein (121).
Two hours ofinhalation exposure resulted inthe same level of
pulmonarycadmiumdepositioninratsexposedtoCdCl2orCdO
aerosol and in the first 72 hr 58% ofcadmium cleared from
CdCl2 and 46% from CdO (121). The difference between the
clearance of CdO and CdCl2 was also negligible after in-
tratracheal administration. Afterthefirst 12 hrclearancehalf-
timebecameapproximately 15daysforbothcompounds (122).
The increase in clearance half-time with the extension ofex-
posureperiodindicatesthatthefractionofpulmonarycadmium
withafastclearancebecomesprogressively smaller.
Afterabsorption intoblood, cadmium is mainly transported
inplasma. Withtimeredbloodcellsbecomethemaincarriers.
Theprincipal tissuedepositoriesofcadmium aretheliverand
kidneyswheremostofthecadmiumisboundtoasulfhydryl-rich
protein (metallothionein) (84). Researchonthemechanism of
Cd-inducedtesticularandprostaticcarcinogenesisrevealedthat
inratsthetestesandprostatearedeficientinmetallothionein. In
theratprostate, acadmium-bindingproteinwas identifiedthat
hasaloweraffinityforcadmiumthanmetallothionein(123). Bin-
dingtometallothioneinisresponsibleforthelongclearancehalf-
time ofcadmium, 200 to 700 days inmice and rats, 2 years in
squirrel monkeys, 10to 30years inhumans (84).
Short-Term Tests
Studies on Salmonella, E. coli, or yeast have produced in-
conclusiveresultswithcadmiumchloride(86,107). CdCl2was
weaklymutagenicandstronglycytotoxicintheSalmnellaassay
(124). Cadmiumnitrate, whichgavenegativeresultsintheplate
incorporatingassay, wasmutagenicintheflucuationassaywith
E. coliandSalmonellaTAI00,thoughnotinotherstains. When,
inordertopreventtheprecipitationof admium,orthophosphate
wasreplacedbytrimetaphophateinthemedium,thefluctuation
assaygavenegativeresultsevenwithSalmonellaTAI00(47). In
the rec assay with B. subtilis, cadmium chloride, nitrate, or
166CARCINOGENIC17Y OF METALS AND INORGANIC METAL COMPOUNDS
sulfatewereweaklypositive(125). Cadmiumchlorideenhanced
themutageniceffectofN-methyl-N-nitrosourea inasynergistic
mannerinS. tphimuriumeitherdirectlybymodifyingthenature
orindirectlybyinhibitingtherepairofmethylationdamage(124).
In L5178Y mouse lymphoma cells, CdCl2 and CdSO4 con-
sistentlyinducedtrifluorothymidine-resistantmutantsinadose-
dependent manner (51,126). In cultured V79 Chinese hamster
ovarycells, CdCl2inducedmutationatthehypoxanthine-guani-
nine phosphorybosyl transferase locus (34). In rat myoblasts,
CdCl2inducedtranscriptionalactivationofproto-oncogensc-jun
andc-nyc, withamaximuminthe5 to 10AMrange(127).
Results ofassays for the induction ofchromosomal abnor-
malitiesbycadmiumsaltsinmammaliancellshavebeenincon-
sistent. CdSandCdSO4inducedchromosomalabnormalitiesin
culturedChinesehamstercellsandhumanleukocytesonlyattoxic
concentrations. Pretreatmentwithlowconcentrationsofcadmium
protected cells againsta subsequenttoxic dose (86). Thereare
conflictingreportsontheinductionofSCEsbycadmium(34).
InSyrianhamstercells,cadmiumacetateinducedtransforma-
tionanddecreasedcloningefficiency. Cadmiumacetateinjected
atanearly lethal dosetopregnantSyrianhamstersonday 11 of
gestationresultedinmorphologicalchangesincellsderivedfrom
progenyexcisedonday 13ofgestationandclonedfromthethird
subpassage(53).Exposureofprimaryculturesofratventralpro-
statecellstoCdCl2resultedinfibroblastoidandepithelialcelllines
characterizedby unlimited growth andchanges inmorphology
andkaryotype. Malignancieswereproducedbythesubcutaneous
inoculationofthesecellsintothedorsalregionofrats(128). Inthe
mouseembryocelllineBALB/3T3,cloneA31-1-1,CdCl2induced
dose-dependentmorphologicalchanges. Allthetransformedfoci
gaverisetotumors.Theseappearedtobefibrosarcomasatthesite
ofSCinoculation innudemice(57).
Cadmiumnitrate(0.18to 1.8AM)increasedunscheduledDNA
synthesis incultured rathepatocyctes'(129) whileUV-induced
unscheduledDNAsynthesiswasinhibitedby4 tMconcentration
ofCdCl2 incultured diploid fibroblasts derived from anormal
child, inSimiankidneycells(130), andinHeLaS-3cells(131).
Zincat4to 10timeshigherconcentrations restoredatleastpart-
lytherepaircapabilityofcells(130). Theeffectofcadmiumon
repairmaybemediatedthroughthereplacementofZninDNA
polymerases. Thehigh Zn:Cd concentration ratiorequired for
restorationmayreflectthehigheraffinityofessentialbindingsites
forcadmiumthanforzinc. However,cadmiumdidsharethein-
hibitoryeffectofzincontheclosureofUVorX-ray-inducedstrand
breaks(131).Inacell-freeinvitrosystem,CdCl2increasedmisin-
corporationofnucleotidebasesintothedaughterstrandofDNA
synthetizedfrompolynucleotidetemplatesbyDNApolymerase
(64). Cadmiumalsoinhibitedoveralltranscriptionandincreased
RNAchaininitiation(34).
With one exception, soluble cadmium compounds, mainly
CdCl2, wereusedintheassayslistedabove. Thepositiveassays
supporttheviewthationiccadmiumisgenotoxic, buttheyleave
open-thegenotoxicityofCdOandotherinsolubleorhardlysolu-
blecompounds.
Conclusions
The results ofepidemiological studies are ambiguous (85).
Though the interest in thecarcinogenicity ofcadmium started
withtheidentificationofunexpectednumbersofprostaticcancer
deathsinagroupofexposedworkers, follow-up studiesfailedto
confirmtheetiological roleofcadmium. Thereasonforthismay
beeitherthatthefourcasesintheUnitedKingdomandfourcases
intheUnitedStateswerefreakclustersorthatexposuredeclined
below the effective level. In contrast, the same follow-ups
revealed increased lung cancer mortality, though with lower
SMRsinthelatethanintheearlyemployedgroups. InaUnited
Kingdom nickel-cadmium battery factory, excess lung cancer
mortality wasfoundonyinthegroupofworkersemployedbefore
1947. Thusitseemsthatdecreaseinexposurenotonlydecreases
the riskofexcesslung cancermortality butcan preventit. The
roleofconfounding variables, suchasoxyacetyleneweldingand
nickelhydroxideinthemanufactureofnickelcadmiumbatteries
orarsenic innonferrous smelters, cannotbe ignored.
Short-term mutagenicity tests and lung cancerdeveloped in
ratsexposedtocadmiumaerosolshavedemonstratedthegeno-
toxic and carcinogenic potential ofcadmium compounds. The
presenceofcadmiuminthecytosolicandmetallothionein frac-
tionsoflungafterexposuretoCdOorCdSdemonstratedthefor-
mationofdissolvedandioniccadmium, whichwerepositivein
several short-term tests. The in vivo conversion of insoluble
cadmium compounds may also explain why in inhalation
experiments there was no consistent difference between the
carcinogenic potential of soluble and insoluble cadmium
compounds.
Cadmium concentrations used in the rat inhalation ex-
periments wereseveralordersofmagnitudehigherthanconcen-
trations inambientairbutlowerthanindustrial stardsorcon-
centrations associated with increasedincidenceoflung cancer
inoccupationalcohorts. Nevertheless, theconcentrations were
highrelativetotoxicconcentrationsforthespecies. Theexposure
necessaryforthedevelopmentofpulmonarycarcinogenesiswas
only slightlylowerthanthedosethatkilledasignificantnumber
ofanimalsandwas withinthetoxic range. Whenexposure was
changedfromthenearlycontinuousto40hrperweek, thesame
atmospheric concentration became less toxic and less car-
cinogenic (110).
The overlap between the carcinogenic and nongenotoxic ef-
fectsofcadmiuminratsandtheexperimental scheduleofthese
experimentsraisesomequestions. Oneisthecontributionofpro-
longed pulmonary inflammation to the carcinogenic process.
The second question concerns the exposure schedule. Con-
tinuous exposuredeliversnotonly 3-foldmorecadmiumtothe
lungthandaily8-hrexposure, butaffectsclearance(see "Kinetic
Considerations") and exhausts protective mechanisms. The
fasterrecoveryofalveolardamageduringintermittent, compared
withcontinuous, exposuredemonstratesthevalidityofthispoint.
Basedontheseconsiderationsandalsoontheresistanceoftwo
species, the mouse and the hamster, extrapolation from cad-
mium-inducedlungcancerinratstolungcancerriskinhumans
mustbe viewed with caution.
Chromium
Epidemiology
Chromiumisusedinavarietyofdifferentformsandoccupa-
tional settings. Thetoxicityofchromiumdependsonitsoxida-
tionstateandsolubility. Fortyyearsago,Baetjer(132)reviewed
pulmonary carcinomas associated with exposure tochromium
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inchromate-producing and chromiumpigmentindustries. As no
cancer wasobserved inplants where exposure was restricted to
bichromates, monochromate dust was considered to be the
responsible agent. In the intervening years the fieldofstudies has
beenextendedto ferrochromium production, chromium plating,
spray painting, and stainless-steel welding. There are several
reviews on the epidemiology of chromium carcinogenesis
(2,133-137). The following discussion is mostly based on com-
prehensive reviews publishedby EPA (136) and Yassi and Niboer
(137).
The firstepidemiological studies covered seven United States
chromate production plants and indicated a nearly 30-fold in-
crease in lung cancer mortality. Further studies covered only one
or three of the seven plants and reduced the condition of
minimum employment from 4 years to
1 or less. Relative risk
decreasedto 15,9, and2. In oneofthe studies theO/Eratio varied
from4to 18 with increasingdurationofexposure. Latencyperiod
clustered around 27 to 36 years. According to two of these
studies, none of the workers was exposed exclusively to hex-
avalentchromium. In a British study of2715 workers with at least
1yearofemployment, lung cancer mortality showed a 2.42-fold
excess between 1949 and 1977. Within this period, a change in
technology (from high lime to no lime) was associated with a
decrease in relative risk from 3.0 to 1.8. In German chromate
worksthe SMRs were approximately the same, butin Hokkaido
Island, Japan, in a cohortof67 active and487 retired chromate
workers with 10to 36 years ofexposure, lung cancer mortality
was50times higher than in the general population ofJapan. A
followup published 4 years later gave only one-third ofthis ex-
ceptionally high value. In this plant, nasal perforation was fre-
quent, andmanyoftheworkers wereheavy smokers. In aTokyo
factory where 896 workers were engaged in the production of
chromium compounds (84% hexavalent and 16% trivalent),
there wasa9.5-fold increase in lung cancer. Riskoflung cancer
increasedwith length ofemployment. Noneofthese studies in-
dicated increased incidences of neoplasms at other sites
(136,137).
Thefirst epidemiological study ofchromium pigment produc-
tion workers found 3 cases of lung cancer in a group of 24
Norwegianworkers with more than 3 yearsofemployment. The
threecases represented a38-fold increase in riskcompared with
the lung cancer incidence of Norwegian males. A follow-up
study found three additional cases. Lung cancer patients were
probably exposedto0.5 tol.5 mg/n3 chromium during their6 to
8years ofemployment. Fiveofthe sixpatients were exclusive-
lyexposed tozinc chromate (133,135). In studies from the United
States, England, Germany, andtheNetherlands, therelative risk
ranged from 1.0 to 3.9. Studiesfrom England and the United
States also reported increased incidences of stomach cancer.
Zinc chromate seemed to be the causative agent in both the
British and one of the U.S. studies (137), but according to the
otherU.S. study, the pigmentplant atNewark, NewJersey, used
nine times more lead chromate than zinc chromate (138). A
multicenter European study confirmed the tendency to elevated
lung cancer risk in workers exposed to both zinc and lead
chromate (139). An update ofthe Newark study, based on the
vital status of 1737 workers, indicated that 30 years or more after
theonsetofexposure to chromatedust, but notearlier, the SMR
oflungcancerincreases with exposure years. Exposure yearsof
0, <1, 1-9, and 10+ wereassociated with 81, 139,201, and 231
SMRs (140).
Inthe ferrochromium-producing industry, exposure is most-
ly to trivalent chromium. The relevance of reports from the
U.S.S.R. onincreasedmortalityfromallmalignancies intheover
50-year age group isdubious. Basic epidemiological data were
deficient and exposure included hexavalent chromium andben-
zo[a]pyrene (134,137). A Swedish study found no increase in
respiratory cancer risk among 1932 ferrochromium workers
(141), while aNorwegian study recorded7 lung cancers among
325 ferrochromium productionworkers instead of3.1 expected.
Exposures included asbestos and low levels of polycyclic
aromatic hydrocarbons. No lungcancerwas recorded inagroup
of243 ferrosilicon workers who were similarly exposed tothese
agents but withoutexposure to chromium (142). In a follow-up
study, the observation period was extended from 1953-1977 to
1953-1985 and the population was increased from 325 to 379
with workers employed between1960and 1965. Inthe original
cohort, 3 new lung cancercases occurred, but none in the sub-
cohort of54 additional men (143).
Inthechromium-plating industry,workers areexposedtothe
mist ofchromium trioxide (chromic acid, a hexavalent form of
chromium). A British retrospective study found 109 (8.8%)
deathsamoung 1238 chromeplaters and85(6.62%) among 1284
matched-control manual workers. The corresponding numbers
fortotalcancerdeathswere 39(3.15%) and21(1.63) andforlung
cancer in 17(1.37%) and 10(0.78%). In the next 2 years, seven
lung cancerdeaths occurred in electroplaters and only three in
controls (144). A second study found in a cohort of2639 nic-
kel/chromium platers significantly increased mortality from
cancers ofthelungandbronchus (72/48.1), nasal cavity (3/0.3),
stomach (25/16.2), andliver(4/0.8). TheO/Eratioswerehighest
inchromebath workers. Excesses inrespiratory cancerbecame
significant 10 years after the start of exposure and showed a
positive association with the duration of chrome bath work.
Althoughfewhighairconcentrations wererecorded(8.0, 1.6,0.4
mg/m3, and some workers developed nasal ulceration, the ma-
jority ofmeasurements recorded lessthan0.05 mgCr/m3 (145).
InItaly, the incidences ofrespiratory cancer (3 vs. 0.7) and total
maligancies increased significantly only in hard platers. The
higher thickness of the plated chrome layer (> 5 tsm versus
0.05,.1.0ism) inhardplating resulted insixtimes higherexposure
to Cr(VI)than in brightplating (146). Two studies from Japan
found no increase of lung cancer among chromium platers
(135,147).
Other occupations investigated for the carcinogenicity of
chromium include spray painting with chromium pigments,
stainless steel welding (137), and cement finishing (148).
Definite conclusions cannot be drawn because the Icelandic
study on cement finishers has notbeen repeated in othercoun-
tries, studies on spray painters arecontadictory, and welders are
exposed to both chromium and nickel. The latest study from a
Norwegian shipyard found increased incidence oflung cancer
among 783 welders. However, unlikethecohortof279machine
shop workers oramong 3610assistants and apprentices, the in-
crease was notsignificant. Therewasaconcomitantexposureto
asbestos (149).
Thereissufficientevidence forthepulmonary crinogenecity
ofchromium. Themostdecisive evidence is fromthechromate
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pigmentandchromate-producingindustries. Exposureistohex-
avalent chromium in the chromate pigment and chromium-
plating industry andtoamixtureofinsoluble (largely trivalent)
and moderately water-soluble and insoluble(largely hexavalent)
chromium compounds in the chromate-producing industry. In
general, epidemiological studieshavenotalteredthetraditional
view that chromates with limited solubility are carcinogens,
while solublechromatesshould notberegarded ascarcinogens
(150,151). Studies oncarcinogenic risk inthe ferrochromium in-
dustry, whereexposure ispredominantly totrivalentchromium,
leftthecarcinogenic roleoftrivalentchromium intheunproven
category (152). In two similarly designed Scandinavian studies,
increasedlungcancer riskwasfound inNorwaywhereexposure
was lower (142) and no risk in Sweden where exposure was
higher (141). AtleastinoneworkplaceoftheSwedishplant, the
total chromium concentration (2.5 mg/m)3 was approximately
thesameorhigherthanthatatindustrieswithincreasedmortality
from lung cancer. Thus, inapigmentfactory, increased cancer
riskbecameapparent inthe0.05- to2.0-mg/m3 exposuregroup
(139)andthetime-weighted averageexposureofchromatepro-
ductionworkerswithincreasedmortality rangedfrom0.11 to0.66
mg/m3 (137). Stainless-steel welders havemuch lowerexposure
tochromium. Onestudygivesthemedianexposure formanual
arc weldingas4ltg and formetal inertgaswelding as 10Ag/m3
(153). Thereis nodefiniteevidencethatchromiumcauses can-
cersotherthaninthelung(11,154)orfbrtheconfoundingroleof
smoking in chromate-induced lung cancer (155).
Animal Experiments
Seveninhalationandfouroral studiespublishedfrom 1959to
1975 andreviewedby EPA(136)wereeithernegativeorfailedto
prove thecarcinogenic potential ofchromium. Inanadditional
inhalation study none of the rats exposed to Zinc chromate
developed lungcarcinoma(156). Lifetimeexposure(6hr/week,
5 days/week for 2 years) to 0.5 mg/m3 or 25 mg/m3 chromium
dioxide (CrO2) produced noadverseclinical signs. Pulmonary
lesions weresimilartothoseinduced bynuisancedusts. Noneof
the 106 male rats and 8 of the 108 female rats exposed to the
higherchromiumconcentrationdevelopedpulmonary tumors.
Tumorsdeveloped infemale rats weredevoidoftruemalignan-
cy (157). Lifelong oral exposures (indietordrinking water) of
mice or rats to trivalent chromium oxide orchromium acetate
werealsowithoutcarcinogenic effect(136). Apositive response
and differentiation between the different classes ofchromium
compounds requiredadministrationbynonphysiological routes.
Though the extrapolation ofthese studies to the conditions of
human exposure is problematic, they allow the comparison of
carcinogenicpotentialofzero-, tri-, andhexavalentchromium.
Studies on chromium carcinogenesis have been extensively
reviewed (2,134,136,137,156).
Thedevelopmentofrhabdomyosarcoma andfibrosarcoma at
IM andSC injection sites was notconsistent. Calciumchromate
gavepositiveresponseintwoofthreeexperiments, leadchromate
in two experiments, andcobalt chromium alloy in one experi-
ment. Negative results weregivenbychromiumpowderin two
experiments and sodium dichromate in one experiment (137).
The intrapleural injection ofhexavalentchromiumcompounds
induced cancer in somebutnot inotherexperiments. Withone
exception, studies with intratracheal instillation gave negative
results. Theexception was an unpublished report reviewed by
EPA (136). Prolonged treatment with weekly doses of 1.25
mg/kg sodiumdichromategiven in asingledose, but not when
it was given in 5 0.25-mg/kg doses, induced 2 pulmonary
adenocarcinomas and6squamouscellcarcinomasin80rats. In
the calcium chromate groups there were one adenocarcinoma
and two squamouscarcinomas. Singleweeklydosesofdichro-
mate or calcium chromate induced 12 and 11 lung adenomas,
respectively.
Morereliableandreproducibleresultswereobtainedwhenthe
testmaterial wasimplantedinastainless-steel wirepelletintothe
leftbronchus. Statistically significant incidenceofprimary lung
carcinomas was seen in ratstreatedwithcalciumchromate, zinc
potassiumchromate, andstrontium chromate. Zinc chromates
consistently increased lung cancer incidence, but not always
significantly. Allthesehexavalentcompoundsaresparingly solu-
ble. Lead chromate-containing materials provided by the in-
dustry wereeithernegativeorlungcancerdevelopedonly in 1%
oftheimplanted rats. Solublechromatesbehavedliketheprac-
tically insoluble lead chromate. Response to the soluble
chromium oxide (CrO3) ranged from0to2 in 100rats, and ne-
gative results weregivenby sodiumchromate, bariumchromate,
and sodiumdichromate. All hexavalentchromiumcompounds
increasedtheincidenceofsquamousmetaplasias, butratsgiven
sparingly soluble chromates had more metaplasia than rats
treatedwithhighly solublechromates. Trivalentchromiumcaus-
edneitherlungcancerorincreasedtheincidenceofmetaplasias
(137,158,159).
Animal studies have confirmed the intrinsic carcinogenicity
of some hexavalent chromium compounds and indicate that
chromiumpowderandtrivalentchromiumarenotcarcinogenic.
Though the two latter forms have been less extensively in-
vestigated, theabsenceofsquamousmetaplasiainratsexposed
to Cr(III) via implantation pellets (159) argues against the car-
cinogenic role ofexposure to trivalentchromium.
Kinetic Considerations
Theabsorptionofchromium fromthegastrointestinal tractis
low. Inmanabout2% andinrats3 to6% ofanoraldoseofhex-
avalent chromium is absorbed. The absorption of trivalent
chromium is even poorer. Data on the urinary excretion of
chromium inchromeplatersindicatethatdermalabsorptionof
hexavalentchromiumcanbesignificant. Thedermalabsorption
oftrivalent chromium sulfate was below the limit ofdetection
(133).
In metallurgy, most of the chromium released into the at-
mosphere is trivalent and in the chemical industry most is
chromate dust. After the intratracheal instillation ofchromate
solution, about 10% ofthedose isabsorbed with ahalf-timeof
1 day in ratsand2 days inguineapigsand 80% iscleared with
30- to40-dayhalf-times. Clearanceofchromateparticles from
thelungdependsonsolubility. Clearanceisfasterafterexposure
tosodiumchromatethanafterexposuretoleadorzincchromate
orchromic chloride. Water-soluble saltsofCr(VI) areabsorb-
ed faster than the water-soluble salts ofCr(IH) (e.g., chromic
chloridehexahydrate) (160). Tenminutesaftertheintratracheal
instillation of200 ug water-soluble hexavalentchromium salts
(chromate or dichromate), 10% of the dose remained in the
lungs, and 25% appeared in blood and in soft tissues. Ten
169L. MAGOS
minutes after the intratracheal instillation of water-soluble
trivalent chromium (chromic chloride), 69% ofthe dose was
found inthelungs, and4% inbloodandsofttissues. Clearance
from the trachea into the laryngopharynx and subsequent
swallowingofparticles wasassumedtoberesponsibleforthedif-
ference. Most ofthe swallowed chromium is excreted in feces
(136).
TheslowerpulmonaryclearanceofCr(Il) maybethe conse-
quence of its more pronounced binding to extracellular
macromulecules, fasterconversion to insoluble forms(133,257),
orhighertoxicity tomacrophages. Thus, inhalationexposureof
rabbits to soluble trivalent chromium but not hexavalent
chromium caused functional damage (increased reduction of
nitroblue tetrazolium and decreased phagocytic activity) in
pulmonary macrophages, while only Cr(VI) increased tie
numberofmacrophages (161).
AfterIVadministration, Cr(Il)clearsfasterfrombloodthan
Cr(VI),probablybecauseCr(VI) israpidlytakenupbyredblood
cells and Cr(III) becomes bound to transferrin. Chromium
clearedfromblood ismostlyexcretedinurineanddeposited in
spleen, liver,andbone marrow, whereconcentrations arehigher
aftertheIV administrationofCr(Ell)thanofCr(VI). Thoughthe
primary route of excretion is urinary, a small proportion is
secretedwithbileandexcretedinfeces. Inhumanvolunteersin-
jected with radiolabeled chromium, Cr(II) cleared from the
wholebodywith ahalf-life of22 daysand Cr(VI) with 92 days
(136). In rats, threedifferentelimination componentshavebeen
identifiedwithhalf-timesof0.5, 5.9, and83.4days(133). A com-
ponentwithlongresidencetimeindeepbody compartments is
responsible forthe morethan 10timeshigherchromium concen-
trationsinautopsy specimensofoccupationallyexposed persons
comparedwithcontrols. The greatestconcentrations werefound
in the hilar lymph nodes and lungs, followed by spleen, liver,
kidney, and heart with equal concentrations (136).
ThemostimportantdifferencebetweenCr(VI)andCr(III)is
thatonlyCr(VI) permeatescellmembraneseasily. Consequent-
ly, while Cr(VI) is highly toxic, Cr(HI) has only a low toxic
potential. However, Cr(VI) is easily reduced to Cr(III). Some
reductiontakesplaceinthegastricjuice, andthis reduction may
be responsible for the low absorption ofhexavalent chromium
fromthegastrointestinal tract. WhilereductiontoCr(IH)outside
the target cells is always a detoxification process, reduction
withincellshas twoimportant consequences: thefirstisthein-
tracellularentrapmentofCr(III)andthesecondistheprolonga-
tionoftheflowofCr(VI) fromtheextracellularpoolintothecell
(162). The intracellular reduction ofCr(VI) is stimulated by
repeated exposure (163).
Thespeedofintracellularreductionisbestdemonstratedwith
the behavior ofCr(VI) in blood. After an IV dose of 1 mg/kg
sodium chromate (VI) to rats, no hexavalent chromium was
detectedinblood 1 minlater(160). Reductiontakesplaceatany
intracellular site where electron donors are present, but the
primarysiteofreductionisthemitochondrion, where thereduc-
tion is enzyme catalyzed and NADH-NADPH dependent
(136,153). Though themainreductionproductisCr(l), in vitro
experiments demonstrated the presence oftransient Cr(V) in-
termediates upon reduction by the mitochondrial electron
transportchain, mainly byNADH:ubiquinone oxidoreductase
andsuccinate:ubiquinoneoxidoreductase (162,164). Ithasbeen
suggestedthatmitochondrial DNAisthetargetofCr(V). Reduc-
tionisconsistently associatedwith inhibitionofmitochondrial
respiration. Inisolatedmitochondria,theinhibitionofmitochon-
drial respirationandthereductionofCr(VI) wereincreasedby
glutamateaselectrondonorand rotenoneaselectronchain in-
hibitor (165). There is experimental evidence for the role of
Cr(III) in this inhibitory effect. Though in intact cells
(hepatocytes orthymocytes), only Cr(VI) inhibites mitochon-
drial respiration, indigitonin-permeabilized thymocytesCr(IM)
wasabetterinhibitorthanCr(VI)inthepresenceofsuccinateand
rotenone (162).
The biological significance ofCr(lI) is demonstrated by its
rolesasanessentialelementandinchromiumhypersensitivity.
Intheglucosetoleranceassay, thelessstableCr(III)compounds
weremosteffective, andsomeCr(VI) compounds weretotally
inactive. Inhypersensitivity reactionsCr(Hl) orCr(VI) reduc-
edtoCr(HI) actsasahaptenandformstheantigenby conjuga-
tionwithprotein. Asintheglucosetoleranceassay,thelessstable
Cr(f)compoundswerethemostactive, itismostlikelythatthe
active agentis the chromic ion (136,155).
Short-Term Tests
Venitt and Levy (166) were the first to show that hexavalent
chromate,butnotchromium(Ell), wasmutagenictobacteria. The
absence ofeither error-prone repair or excision repairdid not
modify the mutagenic response of E. coli to chromate.
Dichromateincreasedmutationfrequency inthelacIgeneinE.
coli (79). Cr(VI) and Cr(HI)acetate inhibited repair in the rec
assay with B. subtilis (60). Chromium(VI) was the most
mutagenic metal ion inthe Salmonella microsomeassay. Only
compoundsinsolubleinwatergavenegativeresults. Cr(M)com-
pounds were inactive (34).
Cr(VI) was weakly positive with Schizosaccharomyces
pombe, at the 8-azaguanine locus with Chinese hamster V79
cells(136), andintheL5178Ymouselymphomaassay (51). Ex-
posureofratliverepithelial(ARL-15C)cellsto 10uMhexavalent
chromate for7 weeks wasmutagenicatthe8-azaguaninelocus,
while2 hrofexposureto 1 mMwasnotmutagenic(167). Solu-
bleCaCrO4, butnotinsolublePbCrO4, inducedmutationatthe
6-thioguaninelocusinChinesehamsterovarycells(168)andin
diploid human fibroblastic cells (169). In diploid human
fibroblastic cells (HFC), cellular uptake, cytotoxicity, muta-
genicity, andanchorageindependencewereinducedbythesame
lowconcentrations(0.2-1.0tiM)ofsolubleandinsolubleCr(VI)
compounds. InsolubleCr(f)compoundsinducedmutationonly
atthe 1000-foldhighercytotoxicconcentration, whileasoluble
formofCrCl3wasnotmutagenicinthesameassay,thoughequal
concentrations (0.1-10 zM)ofsolubleandinsolublechromium
compounds in either +6 or +3 valence states induced similar
frequencies ofanchorage independence (169). Neither ofthe
chromate compounds induced base-substitition mutation as
shown by the absence ofresistance to ouabain (168), and it is
postulated that anchorage independence induced by insoluble
PbCrO4orbyinsoluble andsolubleCr(llI) compounds occurs
by mechanisms not involving base substitution or frameshift
mutations (169).
Cr(VI)inducednumerouschromosomalbreaksinFM3Acells
frommousemammarycarcinoma. Cr(lI)wasineffective(34).
InDonChinesehamstercells(59)orhumanlymphocytes(170)
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strongSCEinductionwasgivenbylowconcentrationsofCr(VI)
andweak inductionbyhighconcentrationsofCr(III). However,
inP388D, cells, Cr(Il) wasastrong inducerofSCE. Ashuman
lymphocytesexcludeCr(111)andP388D1 cellstakeupCr(Il)by
phagocytosis, theultimatecarcinogenseemstobeCr(I)(170).
Compared with the effective concentrations of Cr(VI) com-
pounds, theSCE-inducingconcentrationsofCrCl3andCr2O6in
Chinese hamster V79 cells were 300- and 1000-fold higher in
terms of chromium (171). Crystalline Cr2O6 also caused
concentration-dependent accumulationofcells intheG2phase
and increased up to 10-fold mutations at the hypoxanthine-
guanine phosphoribosyl transferase locus in V79 Chinese
hamster cells. Phagocytized crystalline chromic oxide was
regularly identified in electron micrographs (JIn).
Cr(M) wasnegativeinamammaliancelltransformation assay,
butCr(VI)gaveconsistently positiveresponse(8). Inagreement
with epidemiology or in vivo carcinogenicity data, insoluble
PbCrO4, but not the soluble CaCrO4 induced morphological
transformation and anchorage independence in C3H10T1/2 Cl
mouseembryocells(168). Solubilitywasnotafactorintheabili-
ty ofchromate to transform Syrian hamster embryo cells (55),
BALB/3T3 clone A31-1-1 cells (57), or diploid human fibro-
blastic cells (169). In the last system, Cr(VI) and Cr(HI) were
equally effective (169). Neoplastic transformation was also in-
duced in Syrian hamsterembryo cellsgrown inculture on a 10
to50-nm thick layerofevaporatedpurechromium (173). Forthe
transformation ofratliverepithelial cell line(ARL-15C,), theop-
timumconcentrationandexposuretimewere 1 mMK2CrO4and
2 hr. At this exposure level Cr(VI) was not mutagenic (167).
Sodium dichromategivento 14-day-oldchickembryoshadno
effecton theexpression ofmRNAsforconstitutivegenes (e.g.,
foralbumin), but increased thebasal expression ofmRNAs for
inducible genes (e.g, for cytochrome PB, and P-450) and sup-
pressed the expression of the same genes when induced by a
phenobarbitone analog. Thetimecoursesofthesetwoopposite
effects were bimodal: the first peak corresponded to rises in
Cr(VI)-induced DNA damage, repair, andchromium bound to
DNA, whilethesecond peakcorrelatedclosely withtheforma-
tionofDNA cross-links and strand breaks. Theauthors suggest
that "chromium, like cisplatin, may initially produce a DNA
monoadductthatsubsequently leads tocross-link fonnation and
both typesofchromium(VI)-induced lesions haveasignificant
effectontheexpression oftargeted genes" andthat "theexpres-
sion of inducible genes is more sensitive to the effect of car-
cinogen treatment than isconstitutive gene expression in vivo"
(174).
DNA-protein cross-linksoccurred inproportiontotheconcen-
tration of chromate in several mammalian cells exposed to
Cr(VI) salts. However, Cr(III) but not Cr(VI) induced DNA-
protein cross-links in isolated orsolubilized nuclei. This finding
indicates thatCr(III) is theactive form(175). Inagreementwith
this view, it has been shown that Cr(III) forms Cr-nucleotide
complexes withdissolved nucleic acids. A similarcomplex was
formed inthepresenceofCr(VI)only whenCr(VI) wasreduced
to Cr(III) by excess glutathione (176). However, whenplasmid
pBBR322 DNA was incubated with DNA polymerase, added
Cr(III)did notinducestrandbreaksbutCr(VI) reducedbyperox-
idetoCr(III)did. Strand breaksdid notoccurwhen Cr(VI) was
reduced by GSH or when the incubation medium contained
peroxideandsuperoxidedismutase. Theauthorsconcludedthat
this specific effect is linkedtothe formation ofsuperoxide and
hydroxyl radicals from thedecay ofperoxochromium(V)com-
plexes (177). Thegenerationofthehydroxyl radicalandsinglet
oxygenandcleavageofDNAwasobservedwhenDNA was in-
cubated with sodium chromate in the presence of hydrogen
peroxide (178). Chromium(VI) was co-mutagenic with UV in
CHV79cells(179)butdidnotinhibittherepairofUV-induced
damage in HeLa S-3 cells (131).
Ithasbeenshownthatchromiuminseveraloxidationstates(II,
III, or VI) decreased the fidelity ofE. coli DNA synthesis
(64,180). Atmicromolarconcentrations (0.5-5.0/m), Cr(III)
activates polymerase, probably through thebindingofCr3+ to
polymerase-template. Thiseffect is specific forchromium and
manganese (181).
Conclusions
Chromium is the only metal that is convincingly genotoxic.
Though the current evidence is insufficient to pinpoint car-
cinogenic and noncarcinogenic chromium compounds, it is
apparent that either only sparingly soluble chromates are car-
cinogenic (150) or sparingly soluble chromates are more
carcinogenic than soluble chromates, and the carcinogenic
potency of chromates is some order of magnitude over the
potency oftrivalentchromium compounds (137).
The difference betweenchromates and chromic compounds
seems to reflectthepenetrability ofmembranes forhexavalent
butnotfortrivalentchromium. Thevariationincellularuptake
also explains the strong genotoxic effect ofCr(VI) in in vitro-
exposed, intactcellsandthenegativeorweekresponsetoCr(lI).
Thedifferencebetweenthecarcinogenicpotencyofsparing-
lysolubleandsolublechromatesindicatesthattheprolongedex-
posureoftargetcellstochromium slowlydissolvedfromapool
ofchromiumparticlesismorefavorableforthecarcinogenicpro-
cess than high but temporary exposure to instilled or injected
soluble compounds. Though exposure to sparingly soluble
chromates has the carcinogenic potential, both the kinetics of
chromates andthereactionofCr(HI)withDNAindicatethatthe
ultimate carcinogenic species is mostlikely Cr3+
Lead
Epidemiology
Lead in its compounds has either +2 or +4 valencies. The
bivalent formisthemorestable, anditisthemainformofinor-
ganic leadassociatedwithoccupational andenvironmentalexpo-
sure. Contrary tothehematologic, neurologic, andrenaleffects
oflead, theinterestinleadcarcinogenicity isrelativelynew. Epi-
demiological studies, thesubjectofseveralreviews(2,182,183),
mainly focused on the association between lead exposure and
cancer among workers engaged in the production of lead
(smelters) and storagebatteries. (Leadchromateproduction is
discussed inthe section onchromium.)
Dingwall-Fordyce andLane(184), inthe introductionoftheir
study on leadworkers, wrotethataccording tothereportofthe
Registrar-General intheperiodof1949to 1953, therehadbeen
7 deaths attributed to malignant neoplasms among 1200 lead
burners (burning PbS containing ore to produce PbO). This
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figure indicated a rather better mortality experience than that
which occurred among the general population ofEngland and
Wales. Intheir own study on menbecoming eligible for retire-
ment between 1926 and 1960, they found that 25 years ofex-
posure to lead(100 to250yg Pb/Lurine) in aleadacidbattery
plant was not associatedwith excessofdeaths frommalignant
neoplasms. There was aslightbut notsignificantexcess in an-
cillary workers with leadurine values within normal range. A
follow-up(185) of 1898pensioners from four leadacidbattery
factories found no increase in mortality from malignant
neoplasms between 1925 and 1976. Theanalysis of553 deaths
that occurred before retirement showed that 63 men died of
neoplasticdiseases, whiletheexpectedwasonly48.58. Theex-
cess ofmalignantneoplastic diseasesofthedigestive tract was
evenhigher: 21 comparedwith 12.56expected. Nevertheless, the
authorsconcludedthattheseexcesseswerenottheconsequence
ofprolongedexposure tolead. First, there was noexcess mor-
talityfromcancerinpensioners, andtheexcessmortalityofmen
inservice was almostcompletelyconfined totheperiodof1963
to 1966. Suchdistributionisunlikely tobe relatedtocontinuous
exposure to lead (185).
The study population of these lead-acid battery factories
belonged tothepensionschemeofan internationalconglomerate
with a number ofmanufacturing facilities. The records ofthis
scheme werethemain sourceofdataforacase-controlstudyof
menwhodiedbetween 1926and 1985. Theleadgroupconsisted
of867 menwhohadrelativelyhighoccupationalleadexposure,
and the control groupconsistedof1206 menwith low ornolead
exposure. Inthe leadgroupthere was nostatisticallysignificant
excess in thenumberofdeathsfrommalignantneoplasms, either
ingeneral or atspecific sites (186).
Themortalitydataof3832 workersfirstemployedbefore 1967
in a Swedish copper smelter were followed from 1950 to 1981.
Fromthetotalcohort, 457workers wereselectedwhohadbeen
employed atsiteswithconsiderableleadexposurefor atleast3
years. Basedonregularbloodleadmeasurements,thissubcohort
wasdividedintohigh-meanandlow-meanorhigh-peakandlow-
peakexposuregroups. Meanbloodleadconcentrationdecreased
from582 ,ug/Lin 1950 to 336Ag/Lin 1974. Thestudy indicated
that evenunderconditions regarded asunacceptabletoday, ex-
posure to lead did not increase the incidence of neoplasms
significantly. Noassociationhasbeen shownbetweenexposure
to lead and renal neoplasms(187).
Oneofthelargeststudies, with several follow-ups, was con-
ducted intheUnited States on agroupof7000workers inlead-
battery and lead-producing industries. The first study was
publishedin 1975andreportedasmallexcessofmortalityfrom
cancersofthedigestiveandrespiratory systemsfortheperiodof
1947 to 1970(2). The latest follow-up study by Cooper et al.
(188)extendedtheobservationperiod totheendof1980andin-
cluded 4519 battery plant and 2300 lead production workers.
SMRs werecalculatedfromthedeath ratesofU.S. whitemales.
TheSMRs inthetwocohorts were 113and 113 forallmalignant
neoplasms, 124and 125forlungcancer(includingbronchusand
trachea),and 168and 146forstomachcancer. Theexcesseswere
significantonly inthecohortofbatteryworkers. TheSMRs were
also high for liver cancer but there were only 5 deaths in the
cohortofbattery workersand4 intheleadproductionworkers
(compared with 34 and 9 for stomach and 109 and 41 forlung
cancer). Particularlyintheleadproductionplants(oneprimary
andtwosecondarysmeltersandthreerecyclingplants),therewere
confoundingexposurestoarsenic, cadmium,andSO2. SMRsfor
thegastriccancermortalitymayhaveoverestimatedriskbecause
U.S. rates forwhitemales werelowerthaninthestateofPenn-
sylvaniaormoreimportntlyinPhiladelphia(wherethelargest
batteryplantwaslocated)andinthecountryoforiginofmostof
theforeignworkers. Inbatteryplants, 13of34andinproduction
plants 6 of9 workers who died from gastric cancer were im-
migrants. Other uncontrolled confounding variables were
alcoholicintakeforstomachcancerandsmokingforrespiratory
cancer. Theelevationoflungcancerdeathsfellwithintherange
attributabletoaslightlyheavier-than-averagesmokingpattern.
Monitoringdatawasfarfromsatisfactry.First,theydidnotcover
periodswhenexposurewasprobablytheheaviest; second,they
wereavailableforlessthanone-thirdofthepopulation.Thusitis
not"justifiedinextrapolatingfromtheobservedpatternsofmor-
talitytoriskestimatesthatarerelevanttoleadexposurelevelscur-
rentlyusedorrecommendedasstandards" (188).
In another study, 6 deaths from renal cancerwere identified
when2.94wereexpectedinacohortof1987 smelterworkersin
Idaho.Theexcesswasnotsignificant(189).InanAusbtalianstudy,
theage-standardizedmortalityanalysisshowedadeficitofcancer
deathsbetweenthegroupof242smelterworkerswithahistoryof
leadpoisoningduring 1928to 1959andagroupof695othermale
decedents fromthe samesmelter. The substantial excess inthe
numberofdeaths frombothchronicrenaldiseaseandcerebral
hemorrhage (190) suggests that betweeen 1938 and 1959 the
diagmsisofleadpoisoning(andsuspensionfromworkassociated
withleadexposure)wasbasedonmoreseveredefectsinhemesyn-
thesisandhigherleadbloodlevelsthanatpresent.Therewereno
significantinreases inmortalityfrommalignanciesin2510males
hiredfrom 1952through 1977byachemicalplantwherepotential
exposureincludedinorganicleadandtetraethyllead(191).
Noevidencehasbeenprovidedonassociationeitherbetween
parenteralleadexposureandtheriskofWilm'stumor(adenocar-
cinomawithmixedcarcinomatouselementsthatoccurfetallyand
mayliedormantforyears)orleadconcentrationindrinkingwater
andcancerrisk(192).
Emissionofleadintotheatmosphereofproductionandbattery
plantsiseitherleaddust(mainlyoxide)orvaporfromthemolten
metal. Asvaporincontactwithairisrapidlyoxidized,atleastin
thesetwoindustries, workersaremainlyexposedtoleadoxide.
Cooperetal.(188)reportedurinaryandbloodleadconcentrations
forlessthanone-thirdoftheworkers.Meanurinaryleadconcen-
trationswere130i4g/Linbatteryand 173tig/Linproductionplant
workers. Thecorresponding numbers forblood lead were 627
pg/Land797pg/L.
Inareviewonthecarcinogenicityoflead,Kazantziz(192)did
notamplifyonapreviousLARCevaluationthatacknowldgedthe
absenceofadequatehumandataonthecarcinogenicityoflead.
Severalstudiesarenegative,andsmallexcessriskinotherstudies
could be explained by confounding factors. Nevertheless,
increasedriskobservedissomestudieskeepsconcernaboutthe
humancarcinogenicityofleadontheagenda.
AnimalExperiments
Inthe firstexperimentaldemonstrationoflead-inducedcar-
cinogenesis, ratswereinjectedonceaweeksubcutaneslywith
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1 mLof2% leadphosphate suspension (15.3 mgPb) for2 to 36
weeks. Nineteenof29ratswhichwerealive 10monthsafterthe
firsttreatmentdevelopedtumorsintherenalcortex. Mostofthe
tumor-bearing animals had multiple, expansive, but encap-
sulated tumors, diagnosed as adenomas, but threehad tumors
which infiltrated the neighbouring tissues and twoofthethree
hadmetastases (193). Inadditiontothisstudy, EPA(182)review-
ed several others which showed that intramuscularly injected
lead caused injection-site fibrosarcomas and rhabdomyosar-
comas and that lead, at toxic oral doses, is tumorigenic. The
tumors were mostly adenomas and occasionally malignant
neoplasms. Mostofthesestudiesusedleadacetateorsubacetate
administeredinthediettoratsatconcentrationsof1100 or 10000
ppm. Miceseemedtosharethesensitivityofrats, whilehamsters
wereresistanttothetumorigeniceffectofleadacetate. According
toEPAreviews (182), thesestudiesdidnotprovidemuchuseful
information, astheydonotallowthedeterminationoftherelative
carcinogenicpotencyofleadandtheyhad somedeficiencies in
protocol anddesign.
EPA(182)consideredthatthequestionofleadcarcinogenicity
hadbeenaddressed in a "definite manner" by a2-year feeding
studythatusedtwospecies, twosexes, andawiderangeoflead
acetateconcentrations (194). Unfortunately, boththedescription
ofmethodology and the presentation ofdata lacked important
details. Leadconcentrations rangedfrom0to2000ppmforrats
ofundefined strain and 0to 500 ppm for beagle dogs. A table
givesthe numberofrats ineach sex foreachdietary level, per-
cent mortality, and percent renal tumor incidence. Whether
tumor incidence refers tototal or surviving rats is notdefined,
andinformationgivenonthenatureoftumorsisasinglesentence
which states: "Mostofthetumorswereadenomasderivedfrom
thetubularepithelium" (194). Noneofthedogsdeveloped renal
tumors. Norenaltumorwasobservedinratsat 100ppmorbelow
orin femaleratsat 1000ppmorbelow. Renal tumorincidences
inmale ratswere 10% at548ppm, 50% at 1150ppm, and 80%
at2100ppm. Infemale ratstheincidence rates were0% at 1150
ppm and 35% at 2100 ppm. Other pathological changes (un-
defined) were seen in rats at 500 ppm or higher levels. The
hematologicaleffectofleadwasevidentatadietaryleadconcen-
tration of 50 ppm. Increase in mortality above the high
background levels of37 and 50% in male and 34 and 35% in
femalerats wasnotconsistent, butitreached80% inmales inthe
highest exposure group (194).
Lead acetate and male rats were used in three other ex-
periments. Mortality from acute toxicity was 19/50 in Fischer
ratsexposedto 10,000ppmdietary lead. Surviving ratssacrificed
at 16,24, or36weeksshowedsignsofrenalhyperplasia, andone
of five rats sacrificed at 52 weeks had renal adenocarcinoma
(195). InWistarrats, 24weeksofexposureto6300ppmleadpro-
ducedrenaltumorscomposedofbasophilic, chromophobic, and
oncocyticcells. Exposureto3150ppmhadnotumorigeniceffect
(196). In another experiment, male Sprague-Dawley rats
exposed to 2600 ppm lead in drinking water werekilled when
moribundorat76weeks. Renaltumors, identifiedastubularcar-
cinomas, developed in 13 of 16 rats (197).
Groupsof30maleWistarratswerefedonadietcontaining 1%
lead subacetate (8000ppmPb). Onlyonecontrolsandsevenex-
posed ratsdiedbeforetheendofthe 18thmonth. Noneofthecon-
trols had renal tumors, while 8.7% of the exposed rats had
adenocarcinomas and47.8% hadadenomas. Theearliesttumor
appearedat58weeks. Thesupplementationoftheleaddietwith
0.3% calcium acetate increased the incidence of adenocar-
cinomas to 19.2% andtheincidenceofadenomas to61.5%, and
itdecreasedbodyweightandnearlyhalvedleadconcentrations
inkidneys (198).
InstrainAmice, 24(twiceweekly)IPadministrationsof6.25
mg/kg lead subacetate (basic lead acetate) doubled the high
backgroundincidence (37%)ofpulmonaryadenomas (199). The
inductionoflungtumorswaspreventedbytheIPadministrstion
ofmagnesium orcalciumacetate (200).
Synergisticeffects werereported inthekidneysofratsgiven
lead acetate and N-nitroso-N-(hydroxyethyl)ethylamine or N-
(4'-fluoro-4-biphenyl)acetamide orally and in the lungs of
hamsters given lead oxide and benzo[a]pyrene given intra-
tracheally (50). InN-(4'-fluoro-4-biphenyl)acetamide-treated
rats, 10000ppmdietaryleadacceleratedtheonsetofrenallesions
includingthedevelopmentofrenalcarcinoma(195). Nosyncar-
cinogenicity wasobservedwhenratsweregiven2600ppmlead
intheirdrinkingwaterfor72weeksand, from23weeksonward,
ethylurea (EU) and sodium nitrate (NaNO2) in food. Leaddid
notincreasetheincidenceoflymphosarcoma, andEU/NaNO2
decreasedtheincidenceofrenaltumors(197). Synergistic orin-
hibitory effects were notobserved afterprolongedexposure to
leadacetate(6400Pb indiet)andN-nitrosodiethylamine, though
both acton the same segments ofrenal tubules (196). In Swiss
mice, 15 weeksofexposureto50, 200,or 1000ppmlead(aslead
acetate) in drinking water did not effect urethan-induced lung
adenomaformation. Whenleadwasadministeredattwolevels
(50and 1000ppm)for280dayswithoutanyadditionaltreatment,
mortality from spontaneous lymphocytic leukemia ofthymic
origin, prvalentinthisstrainofmice, incmasedbylowexposure
from25/50to34/50. Thedifferencewas significant. However,
the increase ofmortality from 35/50 to 38/50 by a 40-fold in-
crease inexposure was notsignificant, though lead concentra-
tions increased9-fold inkidney and5-fold in liver(201).
Animal studies leave no doubt that inorganic lead is tu-
morigenic. Somespecies(e.g., hamstersanddogs)didnotres-
pond with tumors, but inrats, prolonged oral exposure to lead
consistently inducedrenaltumors. Intheabsenceofappropriate
experiments, thereisnoevidencethatinhalationexposuretoin-
organic leadiscarcinogenic, andthereisnogoodevidencethat
lead can induce tumors atother sites. The finding that IP lead
subacetate increased the incidence oflung adenomas (199) in
micemay bevalidonly foraparticular strain which has ahigh
backgroundincidenceofthistumor. Thedevelopmentofmalig-
nanttumorsmostlyoccurredinratswhenexposurewasextreme-
lyhigh, e.g., 10000ppmsolubleleadinfoodordrinkingwater.
Thus, inorganic lead belongs to the group ofcompounds that
mustbegivenatorneartothemaximumtolerateddoseandwell
abovethedoseacutelytoxictothetarget. Thereissomeindica-
tion that the site ofacute renal damage is the siteofneoplastic
transformation (196).
Kinetic Considerations
Thegastrointestinal absorptionofingestedsolubleleadis4to
21%. In fasting human subjects, duetothe absenceofcalcium
andphosphateinthegastrointestinaltract,theabsorptionoflead
canbeashighas60%. Childrenage3monthsto8yearsabsorb
173L MAGOS
substantially more than adults. The same difference is seen in
animals: adults absorb 5 to 10% andyoung animals 50%. Ab-
sorption ofleadacetatethrough the intact skin isfrom0to 3%
and more from scratched skin. The dermal absorption of
organolead compounds canbe substantial (182,202).
DatatabulatedbyEPA(182)indicatethatabouthalfofinhaled
lead is retained inthe respiratory tractand mostofthe inhaled
lead(e.g., leadoxide)isclearedfromthelungwithin24hr. Such
arapid clearance explains the lackofleadaccumulation inthe
lungofdeceased leadworkers. Theexceptionistheaccumula-
tionoflead inworkers exposed tolead sulfide (202).
Absorbedleadinbloodislocatedmainlyinerythoyts, and
itisdistributedtosofttissueswhereliverandkidneysaccumulate
thehighestconcentrations. Theinitialdistributionisfollowedby
redistribution between the exchangeable compartment (blood
and soft tissues) and the storage compartment, essentially the
skeleton, wheretheconcentrationcanbe 10to40timeshigher
thanthatinliverorkidneys. Inanimalexperiments, lowdietary
calciumincreasedtheproportionofabsorbedleadinsofttissues.
Highdietarycalciumdecreasedabsorption, andmoreleadwas
carried with calcium intobones (203).
Theclearance half-timeoflead frombloodandsofttisues is
about3to4weeksandfromtheskeletonis20years(204). Ex-
cretionismainlyinurine. Nearlyallthedepositedleadmustpass
through the kidneys where interstitial fibrosis develops when
blood lead concentrations are over 600 tg/L (203). In rats
exposedto500ppmdietarylead,thebloodconcentrationoflead
exceededthisvalue(194). Renotoxicitymaybeanimportantfac-
tor inthetumorigenic effectoflead.
Leadhasbeenshowntointeractwithessentialelements, par-
ticularlycalcium, zinc, andiron(203). Theeffectofcalciumon
theabsorptionanddistributionofleadiswelldocumented (see
above). Thecarcinogenicinteracionofcalciumacetatewithlead
acetate is not clear. Differences in route of administration,
species, andtumorsitesexplainwhycalciumacetateprevented
thecarcinogeniceffectofleadinoneexperimentandpotentiated
itinanotherexperiment. Thepotentiationofleadcarcinogenicity
bydietarycalciumacetatewasnoticeableinspiteofadecrease
inrenalleadaccumulation(198). Thereplacementofcalciumby
lead ions atfunctionally significantbinding sitesmay bemore
important than the effect of calcium on the absorption and
distribution of lead. Lead may substitute for Ca2+ in the
calcium-specificproteincalmodulin, whichstimulatesavarie-
tyofenzymesincludingcalcium-depeidentproteinkinase(10).
ProteinkinaseCisareceptorfortumorpromoters,likephorbol
esters, andthegeneproductsofsomeproto-oncogenes, suchas
c-fosandc-myc, arepotentialtargetsofproteinkinaseCaction
(205). It is noteworthy that lead in picomolar concentrations
stimulatesproteinkinaseC (206).
Short-TermTests
Reviewsonthegenotoxicityofleadindicatethatinorganiclead
isnotmutagenicinmicrobialormammaliansystems(1,2,192).
There are conflicting reports on chromosome aberrations in
mammaliancellsexposedinvivoorinvitrotoinorganicleador
inlymphocytes fromhumsexposedtolead(1,182,183). One
studyrepordthat0.5mMconcentationofleadsulfideandlead
nitateincreasedmutationatthd HRPTlocusinChinesehamster
V79cellsby6-fold. Thisconcentrationwascytotoxic (50% in-
hibitionofcloningability) forthereadilyphagocytizedinsolu-
blePbS butnotforthemore soluble Pb(NO3)2 (207). Increase
in SCE was reported in workers exposed to lead, but not in
childrenwithelevatedbloodleadlevelandotherchromosomal
aberrations (182,192).
LeadacetateinducedmorphologicalhaniformationsinSyrian
hamsterembryocellsinadose-dependentmanner. Transformed
cells cloned and administered to nude mice formed fibrosar-
comas (1,207). Lead oxide enhanced the simian adenovirus
(SA-7)-inducedtransformationofSyrianhamsterembryocells
(54).
HepaticDNA synthesis was increasedinratsaftertheIV in-
jectionof101mole/kgleadnitrate. Maximunwasreachedat36
hr and synthesis returned to normal at 72 hr (208). In Syrian
hamsterembryocells2001&moleleadacetatecausedasmallin-
creaseinDNArepair(209)andinacell-freesystemwithnatural
DNAtemplatesleadchlorideinhibitedthefidelityofDNAsyn-
thesis (64,180).
Conclusions
Knowledgeofthecarcinogenicityofleadischaracterizedby
negative epidemiological studies, thedominanceofadenomas
overmalignantneoplasmsinanimal studies, andthepaucityof
positive short-term tests. Lead compounds are notmutagenic,
andsofar, lead-inducedmorphologicaltransformationhasbeen
observed only in Syrianhamsterembryocells exposed to lead
acetate. Thecrucial evidence for the tumorigenicity oflead is
given by bioassays. The firstexperiment that used a sufficient
numberofcontrols andawide rangeofdietary concentrations
was a 2-year feeding study. It resulted in mostly adenomas in
maleratsexposedto500to2000ppmleadandfemaleratsexpos-
ed to 2000 ppm lead (194). In a similar feeding study, much
higherexposure (8000ppm) inducedrenalcarcinomasonly in
8.7% ofmale rats (198).
Thedisagreementbetweentheepidemiologicalevidenceand
animal experiments may be due to differences in species sen-
sitivity orexposure. Differenceinsensitivityexistsbetween rats
andhamstersordogs,anditmayexistbetweenratsandhumans.
However, even assuming thatthe ratmimics the sensitivity of
man,thenegativeoutcomeofepidemiologicalstudiesisnotsur-
prising. Asthedailyfoodconsumptionofratsapproximates5%
ofthebodyweight, theexperimentofAzaretal. (186)indicates
thatinmaleratsthedailyingestionof25mgPb/kg(500 x 0.05)
and in female rats the daily ingestion of 100 mg Pb/kg is
tumorigenic. Theformervalueisabout3500to5000timesthe
averagedailyhumandietaryintake(210), fivetimesthesmallest
dosethatcanproduceacutehumanpoisoning (211), andabout
100timesthedailyoraldose, whichafter2or3 months forced
thehospitalizationofawomenwithsevereanemia(27% hema-
tocrit),ardthalgia, andperipheralandcentralnervousdisorders
(198). Consiering 10% gastrointstialabsorptionand30% ab-
sorptionfromtheinhaledleadparticles, aworkerof70kgbody
weightwouldhavetobeexposedto70mg/m3leadduringthe40
hgworkingweektoreceivetheequivalentabsorbeddailydose.
Thisconcentrationis 1400-foldhigherdtanthepresentpermissi-
ble exposure limit in the United States and would send the
hypothetical workertothehospitalwitiin weeks ifnotdays.
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Nickel
Epidemiology
Nickel forms aseriesofcompoundswithoxidation statesfrom
-1 to +4, but the most prevalent and commercially and en-
vironmentally significantformis +2. Ithas manyindustrial ap-
plications, butitsprimaryproductionpresentedthemostserious
healthproblems. Thefirst reportthatimplicatednickel as a car-
cinogen wastheannual reportoftheChiefInspectorofFactories
and Workshops in England andWales for 1932 [see Doll etal.
(213)]. The unusually large number ofcases ofnasal and lung
cancer came from a nickel refinery at Clydach, Vklls, which
refined nickel matte (impure metal sulfide) made in Sudbury,
Ontario. After milling the matte and converting copper and
nickel sulfides to oxides by calcination, the two oxides were
separated by the Mond process. Nickel was carbonylated to
volatile (boiling point 43.2°C) nickel carbonyl followed by
decomposition at60°C. Atfirstthehighlytoxicnickelcarbonyl
was blamed for the carcinogenic effect, and the cancer was
recognized as occupational inoriginonly in menworking in a
factorywherenickelisproducedbydecompositionas agaseous
compound. However, based on epidemiological studies this
definitionandtheroleofnickelcarbonylinnickel carcinogenesis
wasdiscardedinfavoroftheroleofnickel-containingdust(213).
The epidemiology ofnickel carcinogenesis has been recently
widely reviewed(2,214-217)andtheInternationalCommittee on
NickelCarcinogenesisinMan(218)updatedandanalyzeddata
from 10previouslystudiedcohortsandsupplementedthemwith
exposureestimates forindividual workplaces. Theseestimates
were derived from the knowledge of chemical processes,
historicalrecordsofplantoperations, andavailableenvironmen-
tal measurements. Thefollowing sectionismainlybased onthe
EPAdocument(214)andthereportoftheInternationalCommit-
tee (218).
Successivechanges intechnology reduced exposuretonickel
attheClydachplant. Astudy was adrmaticdropincancerrisk.
A study that followed mortality to thebeginning of 1972 found
that in menfirstemployedbefore 1930 theO/Eratios wereforthe
carcinoma ofnasal sinuses 56/0.195 and forthe cancer oflung
137/21.98. Nodeaths were attributable to nasal sinus cancer in
men who started work after 1924 and the O/E for lung cancer
decreased to 1.5(8/5.46) in menwho werefirstemployedin 1930
or later (213). The latency period was 20 to 50 years for nasal
cancerandsomewhatshorterforlung cancer. Anytimespentin
thefurnace area or more than 5 years spentinthecoppersulfate
area increased risk (214,218). Data analysis indicated that at
Clydach, increased lungandnasal cancer risks wereassociated
with exposuretosulfidicandpossibleoxidicnickelandthatex-
posure to soluble nickel accentuated risk, thoughthere was lit-
tleevidencethatsolublenickelalone wascarcinogenic. Untilthe
replacement ofthe Mond process, the concentration ofthese
three nickel species exceeded 10 mg Ni/m3. There was no
evidence thatmetallic nickel increasedtheriskoflung ornasal
cancers (218).
Similarhigh exposure tooxidicandsulfidic nickel waspresent
inINCO(International Nickel Company) sinterplants atCop-
per Cliffand PNrt Colborne, Ontario, and in the Falconbridge
Refinery in Kristiansand, Norway. Some men in these plants
werealsoexposedtosolublenickel. Exposureatotherplaces was
low (<1 mg Ni/m3), with the exception of medium sulfidic
nickel exposure (1-4 mg Ni/m3) of one of the 20 cohorts at
Falconbridge, Ontario, andoneofthe 17cohortsatHuntington
Alloys, WestVirginia (218).
Sintering (heatingapowdertoproduceasolidmass)waspart
ofmatteprocessingatCopperCliffandsinteringwasusedwith
calcining at Port Colborn. The O/E ratios were 41/9.68 and
50/17.9forlungcancerand2/0.13and 16/0.2fornasalcancer. In-
creases inlarynxandkidney cancerdeaths, thoughnotsignifi-
cant, werefoundonly intheplantwheresinteringwascoupled
withcalcination (PortColborne). Inathirdplant, locatedwith
theCopperCliffplantintheSudburyarea, sinteringwaspartof
the smeltingprocess. Atthis Conistonplant nocases ofnasal,
larynx, orkidneycancerswereidentifiedandtheO/Eforlung
cancerwas5/1.75. Risksamong INCOnonsinterworkerswere
not elevated significantly (214). The latest follow-up covered
54,509 INCO workers who had been employed between the
beginningof1950andtheendof1976forany periodoftime in
sinterplantsor6monthsormoreinotherworkplaces. Analysis
ofmortalitydataindicatedthattheriskofrespiratorycancerin-
creasedwiththedurationofserviceinsinteringplants(Copper
ClifforConiston inthe Sudbury area) or in the Calcining and
Sintering DepartnentofPortColborneand incidencesoflung
andnasalcancersincreasedwhentheperiodafterfirstemploy-
mentwaslongerthan 15years(219,220). TheInternationalCom-
mitte(218)alsotabulatedO/Eratiosforlungandnasalcancers.
AtCopperCliff, Coniston, andPortColborn, theO/Eratiosof
sinterworkerswere63/20Q51, 8/2.67, and72/30.4forlungcancer
and6/0.17,0/0.02, and 10/0.24fornasalcancer, respectively. In
theSudburyareatheO/Tofnonsinterworkers forlung cancer
was493/444.68 andfornasalcancer4/3.4, whileinthePbrtCol-
bornareathecorrespondingnumberswere30/32.32and0/0.25
(218).
IntheFalconbridgeRefinery,Norwa,cancercaseswereiden-
tifiedinagroupof2247workerswhowereemployedforatleast
3yearsandwerealivein 1953. Betwen 1953and 1979,therewere
82 lung cancer, 21 nasal cancer, and5 laryngeal cancercases.
Four of five laryngeal cancer cases came from the roasting-
smeltinggroup(0/E = 4/Q.6). Exposureinthisgroupwasmainly
toparticulatenickelsubsulfideandoxideandO/Eratiosforlung
cancer(19/5.2)andnasal cancer(5/0.1) werehigh. Thehighest
lung cancer O/E (40/7.3) occurred in electrolytic workers
exposed to aerosols of soluble nickel sulfate and chloride.
However, asleachingofthecalcinedmattewascarriedoutinthe
electrolyticdepartment, exposuremayhaveincludednickelsub-
sulfideandoxide(214,216).
In the group of266 men who had worked at least for 1 year
nearcalcinators atHuntington, therewasasignificantexcessof
nasal cancerdeaths (2 versus0.08expected) withoutexcessof
lungcancer. Nonasalcanceroccurredinthecohorthiredafter
1947 (218).
AtFalconbridgeLtd. (Ontario), nonasalcancerwasobserv-
ed in men inany ofthejobcategories. Riskoflung cancer in-
creasedsignificantlyintwoexposurecategories,minesandser-
vice, andnonsignificantly inmillsand smelters (214). Theex-
tension ofthe follow-up period from 1950-1976 to 1950-1984
foundsignificantexcessriskonlyforlungcancerdeath,with 114
observedversus84.6expected. Withtheexceptionofminesand
smelter, therewaslittleevidenceofanyassociationbetweenlung
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cancer risk and duration of exposure in any other exposure
categories (218). No casesofnasal orlung cancer wereidentified
inworkersofahydrometallurgicalnickelrefineryatFortSaskat-
chewan, Alberta. Exposure was topartiallyoxidizedsulfur com-
poundsofnickel (including Ni3S2andamorphnusNiS) as well
as nickel sulfate andnickel powder (217).
Nickel in some geological formations is associated with
silicate(oxideore)insteadofsulfide. StudiescarriedoutatHan-
naNickel SmeltingCompany, Oregon, indicated no excessrisk
from lung, nasal, or laryngeal cancer in miners or smelter
workers. However, all atmospheric cnncentration values were
below the 1.0mg/m3 TLVvalue (214). In anoxide ore refinery
at Fort Saskatchewan, Alberta, two lung cancer cases were
detected, buttheyoccurredin themaintenance group. However,
a significant excess oflung cancer deaths was reported from a
similar refinery in the South Pacific Island ofNew Caledonia
(216).
Exposuretonickelinnickel-usingindustriesisusuallybelow
0.1 mg/m3. The average air concentration in the personal air
samples of 123 stainless-steel welders was 0.093 mg Ni/mg3
(221). Epidemiological studies indicate low or no excess of
cancerriskinwelders, stainless-steelproductionworkers, metal
polishing andplating workers, and nickel alloy manufacturing
workers. Slightbutsignificant increases in lung cancerdeaths
wereobservedinhigh-nickelalloyplantworkers, die-castingand
electroplating workers, butowing tothepresenceofconfounding
variablesthecausativeroleofnickel wasdubious (214,216,217).
Theavailableepidemiologicalevidenceclearlyindicatesthat
exposure to nickel-containing dust present in the working en-
vironment can cause cancerinnickelproductionworkers 5 to25
yearsaftertheonsetofexposure. Thereisconvincingevidence
for excesses of cancer in lung and nose, but not at other sites
(218). Theinteractionofsmokingwithnickel was animportant
factor inlung cancerdeaths intheNorwegianrefinery(222), but
smokinghistories wereusually notcollected. Canceris notthe
onlyadverseeffectofnickel. Thetargetsofcarcinogenicity are
also the target ofnoncarcinogenic effects and include chronic
pulmonary irritation, hypertrophic rhinitis, and nasal sinusitis,
all ofwhich frequently occur inexposedpopulations (223).
The International Committee on Nickel Carcinogenesis in
Man(218) concludedthatrespiratory cancerrisks areprimari-
ly related to exposure tosolublenickel atconcentrations in ex-
cess of 1 mg Ni/m3 and to exposure to less soluble oxidic and
sulfidicformsatconcentrationsgreaterthan 10 mgNi/m3. Much
oftheevidenceofincreased lungandnasal cancerrisk was seen
inrefinery workers exposed to large amounts ofnickel species
through processes usedinthe past. Forexample, thereduction
oi airbornelevelsofoxidicand sulfidic nickel dustand soluble
nickel mistresulted in thedisappearanceofrespiratory cancer
risk atClydach where inthe calciner the averageoxidic nickel
concentration decreased from 20 to 6-8 mg Ni/m3 and the
sulfidic nickel from6-9 to less than 3 mg Ni/m3.
Animal Experiments
Of all the metals, nickel has the largest literature on ex-
perimental carcinogenesis. The subject has been covered by
several reviews (2,4,214,217,224,225).
Sarcomas havebeenproducedatinjectionsites(mosdyIMand
SCbutalso intafemoral, intraplearal) by severalnickelspecies.
Thereweregreatdifferences inthecarcinogenic potentialofdif-
ferentnickelcompounds. Thus, Ni4FeS4 (sintermatte), nickel
subsulfide, crystalline NiS, NO, and NiS2 induced local sar-
comas in allor nearly all treated rats. Ni powderand Ni(OH)2
had medium and insoluble amorphous nickel sulfide low car-
cinogenic potency. Black nickel oxide (Ni203), colloidal
Ni(OH)2, andthesolublenickelsulfateandnickelchloridewere
ineffective (4,214,217).
TherearespeciesandstraindifferencesinresponsetotheIM
injectionofnickel subsulfide. Theorderofrhabdomyosarcoma
formationindifferentspecieswasrats > mice > hamstersand
in different strains of rats, Hooded > Wistar > Fischer >
Sprague-Dawley. A single intrarenal injection of nickel sub-
sulfideinducedrenaltumorsinFischer, Wistar-LewisandNIH
Black, but not in Long-Evans rats. In rats, intratesticular,in-
traocular, andintrapleural, butnotintrahepatic orsubmaxillar,
injection ofnickel subsulfide induced local tumors (214). Al-
though tumors induced by IM injection were rhabdomyosar-
comas,theyweremainlymalignantfibroushistiocytomasafter
SC injection (226).
TheepigeneticoriginofNi3S2-inducedinjection-sitetumors
issuggestedbythelongperiodofcellularirritation, musclecell
degeneration, andregenerativechangesthatoccurbeforetumors
develop (227). Three weeks after intrarenal injection of
crystallinenickelsubsulfideparticles,subcapsulargranulation,
linearscars, diffuseblackdeposits alongtheneedletrack, and
focal tubularregeneration were seen. Twenty-one weeks after
treatment, all sixratshadrenalmalignancies, mainly sarcomas.
Oncogene amplification was documented in two tumors, and
prominentmarkerchromosomeswereseeninthekaryotypesof
three ofthe six neoplasms. Blood hematocrit values were in-
creasedduring 2 to 36weeks postinjection (228).
Nocarcinogenic effectwasobservedby lifetimeexposureto
5 ppmnickelacetateindrinking waterinmice and rats orby 2
yearsofexposureto 100, 1000, and2500ppmdietarynickel(as
nickelsulfate)inratsanddogs. Thelackofcarcinogenicityatthe
higher concentrations is noteworthy because nickel decreased
growth rate in rats, and the highest concentration decreased
growth and lowered hematocrit and hemoglobin values (214).
The carcinogenicity of skin exposure to nickel has not been
studied. The thrice-weekly IP injection of 15 mg/kg nickel
acetatefor8weeksincreasedtheincidenceoflungadenomasin
strain Amice(200), whiletheonce-weekly IPinjectionor in-
tratrachealinstillation of0.16mg/kgnickelsubsulfidefor5weeks
was ineffecive (229).
There are few data on intratracheal instillation. No lung
tumorswereobservedinhamstersgivenNiOparticlesorinrats
treatedwithnickelpowder(214). Theweeklyadministrationof
1.1 mg/kgnickelsubsulfidefor4weeksbyintratrachealinstilla-
tiondidnotincreasetheincidenceofmalignantornonmalignant
tumorsinmiceeitherinlungoratanyothersites(230). However
one study reported the induction oflung tumors, mainly ad-
enocarcinomas and squamous carcinomas, by the weekly in-
tratrachealinstillationofnickelpowder(10times0.3or0.6mg),
oxide(10times5 mgor 15mg), andnickel subsulfide(15 times
0.063 mg, 0.125 mgor0.25 mg) in rats (231).
In inhalation experiments, low incidence of metastasizing
malignanttumorswereobservedinratsafterasingle30-minex-
posure to0.25 mg/Lorthreeweekly30-minexposures to0.03
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mg/L nickel carbonyl for 1 year. As spontaneous malignant
neoplasms in Wistar rats are rare, even the low incidence of
pulmonary malignancies wasofsomesignificance. Exposureto
0.97mgNi/m3asnickelsubsulfide(70% ofparticlessmallerthan
1 pm) for78to80days (6hr/day, 5 days/week) significantly in-
creased theincidenceofsquamousmetaplasias, adenomas, and
adenocarcinomas in the lungs ofrats (214). Inhalation studies
withmetallicnickelpowderandNiOgavenegativeresultswith
C57BL mice, Wistar rats, hamsters, andguineapigs (215).
Nickel subsulfidepotentiatedthecarcinogeniceffectsofben-
zo[a]pyrene and 20-methylcholanthrene, while manganese
powder and calcium or magnesium acetate inhibited the
tumorigeniceffectofnickelsubsulfide(214,215). Wheninjected
intramuscularly together with nickel subsulfide in the same
suspension, magnesium carbonate (but not acetate) inhibited
(233) andzinc salts sloweddown(233)thecarcinogenicprocess.
The protective effect of carbonate may have been mediated
through the involvement ofnatural killer and phagocytic cells
(232).
In summary, thosenickelcompoundswhichprovedtobeune-
quivocallycarcinogenicbytheinhalation routewerenickelsub-
sulfide and nickel carbonyl. Nickel dustand insoluble or spar-
ingly soluble nickel compounds, with few exceptions, caused
injection-site sarcomas.
Kinetic Considerations
Thegastrointestinal absorption ofnickel is 1 to5% inhumans.
In animals, 90% ofthe ingested dose was recovered in feces.
Bivalentnickelpenetratestheskinatsweatductsandhairfollicles
and binds to keratin (214,234).
Nickel carbonyl freely crosses the alveolar membrane, and
therefore itspulmonaryabsorption is rapid andextensive. Par-
ticles deposited in the conductive airways are cleared by
mucociliaryactionintothealimentarytract. Clearancefromthe
alveolarregionisthroughabsorptionand/orthephagocytosisof
particlesby monocytes, macrophages, andpolymorphonuclear
leukocytes. For somecompounds, thesolubility issignificant-
lyhigherin vivothaninwater. Moreoverthedissolutionofpar-
ticles is much fasterwithin cells thanextracellularly, probably
becausethephagocytizedparticles areexposedtotheacidicpH
of the vacuoles (225,235). There are no reliable data on the
deposition ofnickelintherespiratory tractofexposedworkers.
Ingoldenhamsters, 20% oftheinhalednickeloxideaerosols
(particle size 1.0-2.5 pm) was deposited in the lungs. The
pulmonary clearance half-time was approximately 45 days.
Pulmonarydeposition wasinverselyrelatedtoparticlesizeafter
thelong-termexposureofratstoNiOaerosol. Theabsenceofin-
creasesinnickelconcentrationsinbloodorsofttissuesindicated
negligibleabsorption. Similarresultswereobtainedwithnickel-
enriched fly ash in hamsters. With welding fumes, the
pulmonary clearance halftime was 30 to 66 days. Contrary to
NiO, thepulmonaryeliminationofnickelaftertheintratracheal
instillation ofNiCl2 is rapid. In rats the pulmonary clearance
half-time was 4.5 hr in one study and70% ofthedose cleared
within24hrinanotherstudy. Otherpulmonaryclearancehalf-
times after intratracheal instillation were 72 hr for nickel car-
bonate in mice and about 3 days for nickel subsulfide in rats
(214). Inmice, 40% oftheintratrachealdoseofnickelsubsulfide
reached thealimentary tractand wasexcreted infeces, and the
remaining60% wasexcretedinurine. Lungclearancehadinitial
and final half-times of 1.2 and 12.4 days (236).
Acomparative study showedthat 1 dayaftertheintratracheal
instillation of 1 pmole Ni compounds to rats, the quantities of
pulmonary nickelwere0.13MmolefromNiCl2; 0.14umolefrom
NiSo4; 0.39molefromNi2O-; and0.65jtmolefromNiO. Inthe
next6 days, only thetwohighly soluble compounds continued
toclearrapidly (237). After 12days(238) or 13 weeks(239) of
inhalationexposuresofratsormicetoequimolarconcentrations
ofnickel compounds, NiSO4 produced the lowest pulmonary
deposition, followed by Ni203 and NiO. After the longer ex-
posureperiod, theconcentrationratioswere 1:2.3:24inratsand
1:14.2:51.8inmice. Bothpulmonaryaccumulationandexposure
time before steady state were inversely related to solubulity
(239); the order ofpulmonary toxicity and the order ofwater
solubility were the same (239,240).
Inhalation(6hr/day,5days/week)of0.44mgNi/m3asNi2S3for
12daysproducedscatteredpulmonaryinflammation(241), and
exposure to0.1 mg Ni/m3for 13 weekscausedalveolarmacro-
phagehyperplasiainallandchronicactiveinflammationinsome
oftherats(239). Astheweeklyexposureschedulewasthesame,
itisapointofinteresttocompareairconcentrationsinthisstudy
and the carcinogenic study ofOttolenghi et al. [see U.S. EPA
(214)]. Exposureofrats to Ni3S2 at aconcentration of0.97 mg
Ni/m3 for 78 to 80 weeks induced lung hyperplasia in 64%,
adenomasin7%,andmalignanciesin7% ofexposedrats(214).
Differencesinthepotentialofdifferentnickelspeciestocause
injection-sitemalignancies initiatedresearchoncellularuptake
andpredictorsofcarcinogenicpotential. Sunderman (224) com-
pared the carcinogenic potential ofnickel compounds with a)
their dissolution half-times in serum and renal cytosol; b)
phagocytic indexinratalveolarmacrophages; c)hematocritof
rats after intrarenal injection; andd) the nickel mass fraction.
The best predictor of carcinogenicity was hematocrit. Car-
cinogenicity also correlated with mass fraction, but not with
solubilities or the phagocytic index. Nevertheless, within one
class of nickel compounds (e.g., sulfides), phagocytosis by
alveolarmacrophages, andevenmorebyfacultativephagocytes,
correlated well with carcinogenic potential (242). Heck and
Costa (242) found that potent carcinogenic particulates, like
crystallineNiS, Ni3S2, andNiO, exhibitstrongnegativesurface
chargeindistilledwaterandenterculturedfibroblastcellsrapid-
ly. Noncarcinogenic, amorphousNiS hasaslightlypositivesur-
facechargeandhasalowphagocyticindex, andionicnickelin-
hibitsphagocytosis. Theoutcomeofinvitrotestsdependsnoton-
lyonthepotencyofnickelcompoundtoinduceacertaineffect,
but also on the ability ofcells to incorporate the nickel com-
pound. Thus, when concanavalin A was used to induce
interferons-ca/(3, crystalline NiS had an inhibitory effect in
murineL-929cellsthatactivelyphagocytizedtheparticles, but
notin rat spleencells with lowphagocytic activity (244).
Within 1 week, theintrarenallyinjectedcrystallineNi3S2par-
ticles werephagocytzedbythemesangialcellsoftheglomerulus.
Becausethedissolutionhalf-timeofcrystallineNi3S2is24days
intissues, Ni3S2particleswerenotdetectable 10weeksafterin-
jection, though some Ni3S2 was converted to crystalline NiS,
whichhasalongdissolutionhalf-timeintissues (235). Phago-
cytized nickel particles are known to aggregate around the
nuclearmembrane, andthe released ionic nickel can enter the
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nucleus(235). Contrary tointracellulardissolution, extracellular
dissolutiondoesnotsupplysufficientionicnickelfortheinduc-
tion ofcarcinomas. This is shown by the negative outcome of
treatmentwhen 15dosesof4.4AmoleNi/rat, assolubleNiSO4,
wasinjectedintramuscularly oneverysecondday(245). Thus,
incorporationofparticlesbytargetcellsandintracellulardissolu-
tion seemtobethedecisivefactors incarcinogenesisbynickel
particles.
In summary, these studies indicatethatthe hightoxicity and
rapidclearanceofsolublenickelcompoundsisunfavorable for
carcinogenesis. Thetoxicity, solubility, andclearanceofnickel
subsulfide favorcarcinogenicitybyallowingthesurvivalofani-
malswitharelativelyhightissuedoseandtheprolongedexpo-
sureoftargetcellstoarelativelyhighconcentrationofnickelions.
Short-Term Tests
InvitroassayshavebeencomprehensivelyreviewedbyCoogan
etal. (225)andSunderman (246). Nickelcompoundsarealmost
alwaysnegativeinmutagenicityassayswithS. typhimurium and
E. coli. Thus, thefluctuationassay, whichidentifiedchromate,
beryllium, and cadmium as mutagenic and arsenite, arsenate,
and lead nitrate as nonmutagenic, was negative with nickel
chlorideorsulfate(48). TheexptionwasXprophageinduction
inE. coli whichhasamuchwidergenetic endpoint(247).
Inmutagenicity testsemploying ChinesehamsterV-79cells,
Chinese hamster ovary cells, rat hepatocytes, human diploid
foreskin fibroblasts, and murine lymphoma L51784Y cells,
statistically significant mutagenic effects ofnickel compnunds
wereseenonlyinthemurinelymphomaassay (246). However,
astrongmutagenicresponsewasobservedinratkidneycellsin-
fected with mutant murine sarcoma virus DNA, which has a
defectintheexpressionofthev-mostransforminggene. Abrief
incubationwithsubtoxicconcentrationsofNiCl2inducedaltera-
tions ingeneexpression resulting in the heritableextension of
temperaturepermissivenessofsplicingfrom33°Cto37C (248).
Similarly, astrongmutagenicresponsewasinducedbyNiSinthe
g12Chinesehamstercelllinewithasinglecopyofthebacterial
gptgenestablyinsertedintotheV79genome(249). Nickelions
alsoenhancedUV-inducedmutagenesisinV-79cells(178,250)
and the mutagenic effect of methyl methansulfonate in
polymerase-proficientE. coliandinS. typhimuriumTiOl, pro-
videdtherewasafunctional recAgeneproduct(251). InHeLa
cells, therewasagoodcorrelationbetweentheco-mutagenicity
of Ni(II) with UV light and the inhibition of DNA repair
(131,250).
Mammalian transformation assays gave positive responses
with carcinogenic nickel compounds and some soluble nickel
compoundsofunprovencarcinogenicity. InSyrianhamsterem-
brY cells, NiCl2, NiSO4,Ni2O3, nickeldust, Ni3Se2,crysalline
NiS, andNi3S2producedmorphologicaltansformation. Amor-
phous NiS yielded negative responseand NiO gave equivocal
results. Inagreementwiththeavidcellularuptakeofcrystalline
NiS by phagocytosis andthe moderate uptake ofNi2+ ions by
ionchannels, crystallineNiSwas2.5timesaspotentasNiCl2.
Comparsonofdifferentnickelcom sindicatedthatthein-
tracellularbiailabilityofNi2+ istheproperty thatdetermines
thetransrmingpotnc. Thetransformingabilityofnickelcom-
pounds was confirmed in BHK-21 hamster kidney cells.
Transformation wasobservedalsoincellculturesderivedfrom
the progeny of Syrian hamsters. Mothers were treated with
NiSO4 on day 11 ofgestation, and progeny was excised 2 days
later. In contrast to strongly positive results in Syrian hamster
embryocells, humancellcultureswereonlypartially suscepti-
ble to nickel. Thus, human fetal kidney explants exposed to
NiSO4developedsignsoftransformation, buttransformedcol-
oniesfailedtodeveloptumorsafterimplantationinnudemice.
In human diploid foreskin fibroblasts, only anchorage in-
dependencedeveloped, andnoneofthesignsoftransformation
werepresentinbronchialepithelial cellsexposedtoNiSO4. In
transformationassays, nickelcompoundsacted synergistically
withbenzo[a]pyrene(246). Theabsenceofmutationtoouabain
resistance indicates that the Ni(II)-induced morphological
transformation of 10TI/2 mouse embryo cells was not through
basesubstitutionmutation(55). Abnormalchromosomes, loss
ofnormalchromosomes,andincreasednumberofchromosomes
wereseeninhuman fetalkidney epithelial cellsimmortalizedby
nickelsulfate(252). ThetransformationofSyrianhamsterem-
bryo cells by NiCl2 was inhibited by the presence of MgCl2
(253).
Intraperitoneal administrationofNiCl2to miceandhamsters
causedchromosomebreaksandgapsinbonemarrow. NoSCE
wasobservedinthelymphocytes ofactive and retired refinery
workers. However, inseveralin itrosystems(e.g.,humanlym-
phocytes, Syrianhamsterembryo cells) nickel compounds in-
creased notonly chromosome breakage, but caused SCE fre-
quentlyinadose-relatedmanner(246). Nickelionspreferential-
lydamagedcentromeresandotherheterochromatic regions of
CHOcellchromosomes. Elevationofmagnesiumchloridelevels
reducedthecellularuptakeNi2+ DNAstrandbreaks, andDNA-
protein crosslinking, but did not reduce damage in the eu-
chromaticregions(254). Deletionoftheheterochromaticlong
armoftheX-chromosomewastheonly Ni-inducedkaryotypic
alteration in male Chinese hamster cells. These have hetero-
chromatinalongtheentirelongarmoftheX-chromosomeand
exhibitanunusuallyhighincidenceofnickel-inducedtransfor-
mationcomparedwithcells fromfemales ofthe same species.
Thepotentlymutagenicandcarcinogenicchromatesdonotpro-
duce a predominance ofSCEs in the heterochromatin region
(255,256). In human lymphocyte culture, NiSO4 reduced
chromosomal length, indicating that Ni2+ at least at high
thughnotlethalconcentrations-isapowerfulspindleinhibitor
(257).
TheIPinjectionofnickelcarbonatetoratscausedDNAstrand
breaksandthefonnationofDNA-proteincomplexesinrenalcell
nuclei. DNAstradbreaks werealsoobservedinculturedCHO
cellsexposedinvitrotocrystallineNiS, orN3S2,butnotincells
exposedtoamorphousNiS.However, srandbreaks curredon-
lyatconcentrationsthatreducedcellsurvival(246). Exposure
ofeitherwholeCHOcellsorisolatednucleitoNiCl2increased
inadose-dependentmannerthebindingofsatelliteDNAtopro-
tein (256). Most ofthe proteins tightly bound to DNA were
nonhistonechromosomalproteins(259). BALB/c-3T3cellsthat
survivedexposuretoincreasingconcentrations ofNiC.2retained
resistance to Ni(ll) for many generations. This resistance is
associatedwithheterochronaticabnormalitiesinvolving fusions
atthecentromeres (260).
In vitro submillimolarconcentrations ofNiCI2, NiCO3, and
crystalline Ni3S2 induced transition ofdouble-stranded DNA
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from right-handed to left-handed helical form. Other metals
which have the same effect are cobalt and manganese ions.
Removal of the responsible cations by a completing agent
resulted in instantaneous reversal (246). The complex forma-
tion between Ni(H) and synthetic polydeoxynucleotides with
alternating G-C sequences was associated with conformational
changes. The Ni-oligopeptide complex was insensitive to
DNAse-I digestion and participated in oxygen biochemistry
with the postulated involvement of the Ni(III)/Ni(ll) redox
couple or the (NiO)2+ oxene species (261). The Ni(III)/
Ni(II) redox couple had a role in the in vitro polymerization
ofhistones by Ni3S2 (262). The binding ofNi(ll) to DNA and
the subsequent formation of a nickel-oxygen complex was
assumed to be the reactive species responsible for DNA
damage (178). NiCl2 impaired the fidelity of DNA synthesis
in a cell-free system (64,180). Thus, though the nickel ion in
most of the gene mutation assays gives negative or weakly
positive responses, it has a high gentoxic potential in several
other assays.
Conclusions
There is convincing evidence that nickel dust, present in the
working environment, can cause cancer in the lung and the
nose. There is some indication that cancer risk is attributable
to oxidic and sulfidic nickel andthat soluble nickel compounds
enhance thecarcinogenic riskofexposure to less soluble forms.
In animal experiments, carcinogenicity depends on the route of
administration. Injection-site tumors can be caused by nearly
every insoluble or sparingly soluble nickel compound and also
by nickel powder, whileonly nickel subsulfide wasconsistently
carcinogenic after intratracheal instillation or inhalation. The
moderate solubilityofnickel subsulfideparticlesallows time for
phagocytosis, and the aggregation of particles around the
nuclear membrane where slowly released nickel ions can enter
the nucleus and react mainly with heterochromatin. The car-
cinogenic dose is higher than the dose that produces chronic,
active pulmonary inflammation.
The mutagenicity ofNi(ll) in bacterial and mammalian cells
ranged from negative to weakly positive. Strong positivity was
obtained when viral or bacterial genes were introduced into a
mammalian cell system. Although Ni(ll) is atbest avery weak
point mutagen, it is strongly clastogenic, inducing
chromosomal breaks, gaps, deletions, and SCE. DNA strand
breaks, inhibition of excision repair, and morphological
transformations are induced by Ni(ll) in several mammalian
cell systems. Ni(ll) is alsoactive in cell-free systems, as shown
by increased binding ofDNA to proteins, helical transforma-
tion, and impairment ofthe fidelity ofDNA synthesis.
Though the causal role of these interactions in nickel car-
cinogenesis is unproven, theydemonstrate theability ofnickel
to induce genotoxic events. Sunderman (246), who in his
review listed additional interactions (blocking cell-to-cell com-
munication, stimulating lipid peroxidation, reacting with the
finger-loop domains oftransforming proteins), expressed the
view that "a clear delineation of the cellular and molecular
mechanismsofnickelcarcinogenesiswillbeachievedbytheyear
of2000."
Miscellaneous Metals
Antimony
Aftertheintroductionofcontrol measuresin 1960,theaverage
atmosphericconcentrationofantimony was nearly20-foldthe
0.5mg/m3TLVinanantimony smelter. Itismostlikelythatex-
posure before 1960 was substantiallyhigher. No excess deaths
occurredamongthoseemployedafter 1958, butthelungcancer
mortalityofworkersemployedbefore 1958 showeda2-foldex-
cessoverthenumberexpectedfromlocalmortalityrates. Sixof
the fifteen who died oflung cancer were very heavy or heavy
smokers, 5 weremoderatesmokers, onewasalightsmoker, and
2wereclassifiedasnonsmokers (32). Arsenic inantimonyore
as well as smoking mighthavebeenconfounding factors.
Prolonged inhalation exposure (7 hr/day, 5 days/week, up to
1 year) to36to45 mg Sbmg/m3 intheform ofantimony triox-
ide (containing 80% Sband40ppmAs) orantimonyore (con-
taining46% Sband792ppmAs)inducedlungtumors, including
carcinomas, in 26% of female rats, but none in male rats.
Pulmonary antimony concentrations were 1.5-fold higher in
malesthaninfemales, whiletheconcentrationofarsenicwasthe
same. In other tissues, arsenic concentrations were higher in
femalesthaninmales. Thissuggeststhatifarseniccontributed
tothecarcinogenicprocess, thesystemicconcentrationofarsenic
was moreimportantthanthepulmonary concentration (263).
SeveralantimonycompoundswerenegativeintheAmestest
and recassay (4). Inthe recassay withB. subtilis, Sb(VI) was
stronglyandSb(lI)weaklypositive(125). Sb(III)enhancedthe
transformation of Syrian hamster embryo cells by simian
adenovirus (54).
Cobalt
IncreasdlungcancermortalitywasobservedinSovietcobalt
recovery workers whowerealsoexposedtoarsenicandnickel
(2,5). In animal experiments, cobalt induced injection-site
malignancies (4). Multiple IP administration of cobalt(III)
acetatedidnotincreasetheincidenceoflungadenomasinstrain
A mice (200). Inhalation exposure to aerosols ofCoO or in-
tratracheally instilled cobalt dust was not tumorigenic in
hamsters (4).
CoC12wasnotmutagenictoSalmonellastrainsinplateincor-
poration andfluctuationassays (48)and itwasalsonegative in
theE. coli Xprophageassay(247). IntherecassaywithB. sub-
tilis CoC12 was slightly positive. In mouse lymphoma cells,
cobalt(ll) chloride was not mutagenic (126), and in Chinese
hamstercells itwas slighdymutagenicatvery lowratesofcell
survival (264). TreatmentwithCo(ll)resultedinthefollowing
in vitrochanges in mammalian cells: increased SCE in human
lympiocytes (34), moderateenhancementofthetransforration
ofSyrianhamsterembryocellsbysimianadenovirus(54), DNA
strand breaks (34) and increaed DNA-repair synthesis in
culturedCHOcells(209). Co(ll)increasedmisincorporation in
thedaughterstrandofDNA incell-free systems (64,180).
Copper
The intratesticular injection of CuS04 or CuC12 induced
testicular tumors in mice and chicken. Intramuscularly or in-
taperitoneallyadministeredcopperpowder, copperacetate, and
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coppersulfidewerenotcarcinogenicinthemouseorintherat.
The induction ofinjection-site tumors produced by Bordeaux
mixture(amixtureofcoppercompoundsandcalciumarsenate)
has been attributed to arsenic (4). Cu(III) was negative in the
mouselungadenomatest(200). Coppercompoundssuppress-
ed the carcinogenicity of ethionine, dimethylnitosamine,
dimethylbenz[a]anthracene, andthepromotingeffectofphorbol
esthers (4).
CuCl2wasnotmutagenic toSalmonella strains inplateincor-
porationandfluctuationassays (48). Itwasalsonegative inthe
E. coliXprophageandtheTrp+ reversionassay, butitenhanced
UV-inducedmutagenesis(247). Cu(II)wasmutagenic inCHO
cells(34)andcausedaslightincreaseinDNA-repairsynthesis
(209). CuCl2moderatelyenhancedthetransformationofSyrian
hamsterembryo cellsbysimianadenovirus (54) andincreased
misincorporation in thedaughter strandofDNA (64,180).
Iron
Increased lung cancer mortality was observed in hematite
miners inEngland, Sweden, France, andtheU.S.S.R., butnot
in Minnesota. Exposure included radon and radon daughters
(2,5). Someepidemiological studiessuggestthathighbodyiron
stores increasethe riskofcancer (265,266).
Injection-sitemalignancies wereinducedbytheSCinjection
ofiron-dextran(4). Irn(II)2,4-pentanedionewasnegativeinthe
mouse lungadenoma assay (200).
InhalationexposureofSyrianhamsterstoferricoxide(Fe203)
dust enhanced diethylnitrosamine tumorigenicity in the peri-
pheral lung (267). Dietary iron (3.5% Fe-fumarate) enhanced
dimethylhydrazine-induced coloncarcinogenesisinmice(268).
A single dose ofFe-dextran (600 mg Fe/kg) sensitized A/h-re-
sponsiveC57BL/lOScSnmicetotheinductionofhepatocellular
carcinomabypolychlorinatedbiphenyls(269). Pretreatmentof
mice with iron-dextran (two IP doses of 12.5 mg Fe/kg, 12 hr
apart)enhancedthegrowthofL1210tumorcells, whichwerein-
oculated into the peritoneum 6 hr after the second iron dose
(270).
Mutation to 6-thioguanine resistance was induced in CHO
cells by Fe(IE). NeitherFe(ll) norFe(III) induced SCE in Don
Chinese hamster cells (34). Fe(ll) caused no morphological
transformationinSyrianhamsterembryocells(53)butenhanced
transformation inducedby simianadenovirus (54). The fideli-
ty ofDNA synthesis wasnotalteredbyFe(ll) (180).
Manganese
Therearenoreportsindicatingthatmanganeseisahuman car-
cinogen. Inrats, manganeseacetylacetone (suspendedintrioc-
tanoin), butnotpuremanganesepowderormanganesedioxide,
inducedinjection-sitetumors(2). TheprolongedIPadministra-
tion of manganese sulfate increased the incidence of lung
adenomas in strain A mice (200).
Manganesechlorideorpotassiumpermanganategavenegative
responseinseveral Salmonellastrainsinbothincorporationand
fluctuationassays(48)butwaspositiveintheE. coliXprophage
assay (247). Manganese was mutagenic in yeast and bac-
teriophageT4. Ithasbeen suggestedthatmanganeseacts as an
error-producing factor in yeast mitochondrial DNA through
the replacement ofthe magnesium cation in DNApolymerase
(2). Mn(ll)inducedresistanceto8-azaguanine in CHOcells. In
human lymphocytes, Mn(U) produced an increase in the in-
cidenceofSCE (34).
In C3H mouse mammar carcinoma (FMSA) cells, 1 mM
Mn(ll)orMn(VII)inducedchromosomalbreaksandexchanges
inabout5% ofcells. Abovethisconcentration, Mn(VHI)increas-
edaberrationstoahigherlevel, whereasthecytotoxiceffectsof
Mn(l)precludedscoring(271). In viothecationicandanionic
saltsofmanganesewereclastogenicinmousebonemarrow. In
relationtotheirrespectiveLD50doses,manganesechloridewas
amorepotentclastogenthanpermanganate(2fl). However, the
analysisofthedataindicatesthatonamoleperkilogrambasis,
thetwocompoundswereequallypotentclastogensandthatthe
totalnumberofchromosomalaberrationswasincreased moreby
permanganatethanbyMnC12. TheinsolubleMnSmaybemore
genotoxicthanthesolubleMnCl2. Manganesesulfide, whichis
takenupbycellsthroughphagocytosis, inhibitedthegrowthof
Chinese hamster V79 cells at less than 1/100 ofthe inhibitory
doseofthesolubleMnCl2 (247). Mn(ll)decreasedthefidelity
ofDNA synthesis in cell-free systems (180).
Selenium
Epidemiological studies gave conflicting views on the car-
cinogenicity and anticarcinogenicity of selenium. Both the
epidemiological and experimental evidence of selenium car-
cinogenesis havebeen reviewed by aWHO TaskGroup (273).
Thegroupdidnotaccepttheconclusionsoffivestudiesbecause
ofshortcomings indesign orevaluation. Thegroupalso noted
thatseleniteandselenatehadinducedhepaticmalignanciesonly
atexposurelevelsthatproducedlivercirrhosis. Thesixth study
observednosignsofneoplasiainmicegivenseleniteinthedrink-
ingwater(upto8mgSe/L)for50 days,andintheseventh study,
15 mg/kg SeSgivenbygavagefor 103 weeks (5 daysperweek)
induced hepatocellular carcinomas in both male (29%) and
female(42%)rats. When 100mgSeS/kgwasgiveninthesame
scheduletofemalemice, theincidenceofcancerwasthe same
as in female rats given 15 mg/kg. Male mice were resistant.
Alveolar/bronchial carcinomasdevelopedin8% offnalemice.
Nevertheless, theWHOlskGroupconcludedthattheavailable
experimentaldatawereinsufficienttoallowtheclassificationof
inorganic seleniumas acarcinogen.
Ithasbeenshownthatseleniumdioxideandsodiumselenite,
giveninfoodordrinkingwater, haveapreventiveeffectchemi-
cally induced and spontaneous, presumably virally induced,
cancers. Generally,thelevelrequiredforprotectionrangedfrom
1 to 6 mg/kg food or drinking water. Such a supplementation
resultsinintakesthatareconsiderablybelowintakesusedincar-
cinogenesis studies, butthey areconsiderably in excess ofthe
animal's nutritional needs (273).
SelenatewasmutagenictoSalmonellaintheplateincorpora-
tionassay(48)andSeO2gavestrongpositivereactionintherec
assaywitha subtilis(125). Intherec assay, selenatewaslesspo-
tentthanselenite,butinculturedhumanfibroblasts, Se(IV)and
Se(VI)inducedDNArepairtothesameextent. Seleniteincreas-
edDNAfragmentationinhuman fibroblastsandinreasedSCE
inhumanlymphocytes(27?). Selenitedecreasedthemutagenici-
tyofseveralorganiccompoundsandexertedanantagonisticef-
fectagainstclastogens (273).
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Zinc
Thereare noobservationstosuggestthatzinc isahumancar-
cinogen. Onthecontrary,thereissomeindirectepidemiological
evidence that zinc deficiency may increase susceptibility to
esophageal carcinogenesis (4). Inanimalexperiments, only in-
tratesticularadministration inducedcancer. Whenadministered
by this route, zinc chloride or zinc sulfate induced testicular
teratomas in the fowl, rat, and hamster (4). Zinc acetate was
negativeinthemouselungadenomaassay(200). Theeffectsof
zinc chromate or the complexes ofzinc with dithiocarbamate
derivatives (e.g., zineb) areindependentofthepresencezinc.
Zincantagonizedthecarcinogenicity ofcadmium(seesection
on cadmium) and some organic compounds. There is some
evidencethatzincdeficiency increases susceptibility tocancer,
thatsmalldosesprovideprotection, andthatprolongedexcessive
zincintakepromotestumorgrowth(4). Dietaryzincdeficiency
(7 g/gorlessinthediet)suppressedthegrowthoftransplanted
tumor cells in DBA/2 mice. The effect ofhigh dietary levels
(>200ttg/g) was equivocal (274).
Zinc(II)was notmutagenic toE. coli(166). TheE. coliXpro-
phage assay was also negative with zinc (247). Zinc(ll) induc-
ed resistance to 8-azaguanine in CHO cells (34) but not to
trifluorothymidine inmouselymphomacells (126). Zinc(ll)did
not induce morphological transformation (53) but moderately
enhanced simianadenovirus-inducedtransformation in Syrian
hamsterembryocells (54). Thereis noindicationthatzinc can
causechromosomaldamage, DNAstrandbreaks, orthatitcan
alterthe fidelity ofDNAsynthesis (55).
Conclusions
Several ofthemetalsdiscussed inthissectioninfluencedcar-
cinogenesis, butonlyonemetal, antimony, hasbeenimplicated
as a carcinogen by both epidemiological and experimental
studies. All the other seven metals are essential elements, and
theirinfluenceoncarcinogenesis rangesfromprotectiontopro-
motion. Most ofthese metals, with the exception ofSeS, were
ableto causeonlyinjection-sitemalignancies, andzincwasable
to cause injection-site malignancy only after intratesticular in-
jection. Theoutcomeofshort-termtestsdoesnotshowaconsis-
tentpattern. Eachofthesemetalswasnegativeinsometestsand
positive in others.
Summary Conclusions
The first report on metal carcinogenesis, published in 1926,
described testicular teratomas that developed after the in-
tratesticular injection ofzinc chiorideto roosters (2). Though
laterthesameresponsewasobservedintwootherspecies, zinc
was notevenconsideredforcarcinogenicity evaluationby[ARC
(50). According to one definition, a chemical is likely to be a
humancancerriskifitisa)reliablyactiveinabatteryofshort-
term tests; b) definitively active (high yield of specific neo-
plasms, latent period less than 18 months) in several bioassay
systemsinvio; andc)exhibitsactivityoverarangeofdoselevels
(275). Whilezincdefinitelydoesnotfitintothiscategory, none
ofthe metalssatisfy all theserequirements. Itisusual thattest
results includeoneofmoreofthefollowing findings: a) short-
termtests arenotuniformlynegativeorpositive; b)tumorsare
induced only after a particular route ofadministration; c) the
overlap between tumorigenic and toxic doses prevents the
demonstrationoftumorigenicityoverarangeofdoselevel; and
d) only benign tumors areinduced.
Theuseofshort-termtestshassomeinherentdifficulties. The
Salmonellaassaydetectedonlyabouthalfofasampleof44ro-
dentcarcinogensandmorethan30% ofrodentnoncarcinogens
werepositiveinthe assay (276). As usually abattery oftests is
used, each testhaving adifferentsensitivity, theend result is a
mixtureofpositivesandnegatives. Thesamemetalmaybenon-
mutagenicintheSalmonellatestandmutagenicinE. coli; itmay
benegativeinbacterialassays, butpositiveinmammaliangene
mutationassays. Onlyoneofthe 10metals, listedinTable2, was
unequivocally mutagenic in standard bacterial assays, though
many were positive in the E. coli X prophage assay, in bac-
teriophage T4, and inyeast, or in mammalian cells.
Inadditiontogenemutationassays,thereareseveralothertests
thatmeasureinculturedmammaliancellsbiologicalchanges(in-
duction of cell tranformation, SCE, unscheduled DNA syn-
thesis) related to, but without proving, mutagenicity and car-
cinogenicity (276). Nickel was nonmutagenic in mammalian
cells, though itbecamemutagencic when the sensitivity ofthe
system was increased with inserted viral or bacterial genes.
Several metals were negative inmorphological transformation
tests but were able to enhance virally induced transformation.
However, themostsensitivetestmaynotbethebestpredictorof
animal and humancarcinogenicity. It is a reflection on doubts
concerningthepredictivevalueofgenotoxicityteststhatoneof
the three alternative solutions proposed by Ashby (276) is to
"abandontheuseoftheavailablegenotoxicityassaysandtocon-
tinuewiththeexclusiveuseofrodentcarcinogenicitybioassays
forthepredictionofpossiblehuman carcinogenhazards." Oters
believethatatthepresenttimebothtestsareneededbecausethe
strategyofextrapolationtohumanriskisdifferentforgenotox-
ic and nongenotoxic carcinogens (277). The classification of
nongentoxic agents as potential human carcinogens requires
understanding ofthe mechanism ofaction, reasons for target
organandspeciesspecificity, andthequantitativedose-response
relationshipbetweenendpoints suchas inducedcellprolifera-
tion and carcinogenicity (278). In the field ofmetal carcino-
genesis, thefirstobstacleforsuchaclassificationisthatdoseand
route of administration often have no relevance to human
exposure.
Though intratesticularadministration did not mimic human
exposureandlocaltumorsdevelopedatthesiteofparenteralad-
ministration are not a valid measureofcarcinogenicity (279),
bioassaysforinjection-sitetumorshavebecomepopularmodels
for the identification ofcarcinogenic metals and metal com-
pounds. Table2, whichcompares supporting evidence for the
carcinogenicityof10metals, showsthattherouteofadministra-
tiononlyrarelysimulatesrouteofhumanexposure. Compared
withdietary,drinkingwater, orinhalationexposure,parenteral
orintratrachealadministationisprecise,notlaborintensive, and
the treatment period is short (maybe only one injection).
However, concentration at the site usually exceeds concentra-
tionsthatcanbeachievedbyoralorinhalatorydosing. Thecon-
centration of substance in a relatively small tissue volume
enhancesthepossibilityofsevereinjection-sitedamage. Final-
ly, though a positive reaction identifies the test material as a
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lIbIe2. Comparison ofepidemioogical evidence withexperimentalcarcinogenicity andgenotoxnc reactions.
Experimental
Gene Chromosomal Cell trans-
Metal Epidemiology Bioassays mutation! recAssay damage, SCE formationb DNA fidelity
As Lung and skin carcinomas Lung adenoma by intratracheal -(b), ±(m) + + i
administration
Be ? Osteosarcomaby IV, lung cc by inhalation or -(b), +(m) + + i +
intratracheal administration
Cd Lung cancer (confounders?) Lung cancerby inhalation(only in rats) ±(b), +(m) + Inconsistent i +
Co Noproof Sarcoma at IM injection site -(b), ±(m) + + e +
Cr Lung cancer Sarcoma atIM injection site, lung cc by im- +(b), +(m) + + i +
planted pellets
Ni Lung and nasal carcinomas Local malignancies at various injection sites; -(b), -(m) - + i +
lung cc by inhalation ofNi-subsulfide
Mn Noproof Lung adenomaby intraperitoneal -(b), +(m) - + e +
administration
Pb Inadequate SC: renal carcinoma; feeding; renal -(b), ±(m) - Inconsistent e +
adenoma; IP; lung adenoma
Sb Lung cancer Lung cancerby inhalation (only in female ? + + e ?
rats)
Zn None Testicular teratoma by testicular injection -(b), ±(m) ? ? e
'(b) bacterial; (m) mammalian cells.
bi, inducer; e, enhancer.
potential carcinogen, the carcinogenicity ofthe metal may be
restricted to the injection site. This was the case with zinc
chloride.
Theinterpretationofbenigntumorsdoesnotpresentproblems
whentheirincidenceisincreasedwiththeincidenceofmalignant
tumors. When there are only benign tumors, they have only a
limitedvalueasindicatorsofcarcinogenic potential (280), and,
inthehierarchyofevidence, adenomasalonehavelessvaluethan
thepresenceofmalignanttumors. Inadditiontothegeneralpro-
blemofbenignversusmalignanttumors, thevalueofthemouse
lung adenoma assay is questionable on two grounds. First,
animalsthatdevelopbackgroundtumors(e. g., lungadenomain
strain A mice) inhighyieldpossibly do so in waysthatare not
relevanttootherspeciesorstrains(281). Second, thepredictive
value ofthe assay for metals is low; it was positive for nickel,
manganese, molybdenum, andnegative forarsenic, cadmium,
chromium.
A more general problem is the toxicity of metals at car-
cinogenicdoselevels. Thus, theimmediateconsequenceofzinc
chlorideinjectedintothetesteswasnecrosisfollowedbychronic
inflammation. Suchcircumstances raisethepossibilitythathigh-
dosetoxicitywasresponsibleforcancerinitiation. Cellularpro-
liferation provides a favorable milieu for several stages ofcar-
cinogenesis (278,231). Local trauma followedbycellularpro-
liferation is a common observation in carcinogenicity studies
with metals. Whatever the route of administration, the car-
cinogenicdoseofametalalwaysinflictednongenotoxicdamage
on the carcinogenic target. Thus, kidney tumors developed at
very toxic doses oflead and generally only in animals thatex-
perienced obvious acuteleadtoxicity, includingkidney injury.
The prelude to the induction of pulmonary carcinoma by
beryllium, chromium, and nickel was always cell death and
chronicinflammation. Forsolvingtheproblem, Roe(282)sug-
gested that tests for carcinogenicity be carried out at realistic
levelsofexposureorjustabove. Moreover, DNAabnormalities
can be incurred by more subtle reactions than cell death and
chronic inflammation. Thus, without any exposure to a car-
cinogen, significantly more tumors, including malignancies,
developed inratsfedadlibitumthaninratsgiven20% lessfood
(282).
The local damage caused by the testicular injection ofzinc
chloride indicated its dissociation to hydrochloric acid and
biochemically active Zn2+. As Zn2+ inhibits and stimulates
severalenzymaticreactionsanditispresentinRNApolymerases
(283)andinthefinger-loopdomainsinDNA-bindingproteins
that are regulators ofgene expression (284), it ispossible that
HCI, astheprimarycauseoflocaltraumaandcellularprolifera-
tion, and Zn2+ shared the responsibility for the induction of
cancer. It is an attractive hypothesis that the ultimate car-
cinogenicformofametalisitsioninaparticularoxidationstate,
e. g., Ni2+, Cr3+, or Cd2+, which must be delivered to or
formed in the target cells. The proof ofthis ionic hypothesis
wouldbetheidentificationofthosechemical reactionsthatare
responsibleforcarcinogenesisandtheparticipationoftheionin
thecrucialreaction. Atpresentsuchanidentificationisnotpossi-
ble, mainlybecauseofgapsintheknowledgeofthecellularand
molecular mechanism ofmetal carcinogenesis. Moreover, the
single-ion hypothesis ischallengedbyobservationsthatindicate
thatsomeofthegenotoxicreactionsarecatalyzedbyaredoxpair
[Ni(III)/Ni(H)] or an unstable intermediate oxidation state
(Cr(V)].
Fromthepractical point ofview the main question is not so
muchtheexactdefinitionoftheultimatecarcinogenbuttherela-
tionshipbetweenthechemicalandphysicalformsofmetalsaten-
tryintothebodyandcarcnogenesis. Differencesindissolution,
twansportthoughmembranes,phagocytosis, changeinoxidation
state, andthesiteofthischangecontribute tothisrelationship.
The influence ofthesebackground factors change from one
metaltoanother. Inthecaseofchromiumthemostlikelyulimate
carcinogenisCr3+ formedwithinthecell, thoughthecontribu-
tionofanintermediaryoxidationstate[Cr(V)J cannotbeexclud-
ed. AsCr(M)isunabletocrosscellmembranes,theextracellular
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reductionofCr(VI)toCr(L) isadetoxificationprocess, andex-
posuretoCr(L)doesnotsharethecarcinogenic potentialofex-
posure to Cr(VI).
Forarsenic, thedivisionofrolesbetweenAs(V)andAs(IH) is
less distinct, but as pentavalent arsenic is rapidly converted to
trivalent arsenic and the clastogencic potential of As(IE) is
severalfoldtheclastogenicpotentialofAs(V),theactivespecies
is most likely AsO-.
Berylliumandcadmiumexists only inthebivalentoxidation
state, whereasleadandnickelexistpredominantly inthebivalent
oxidation state. The available data are insufficient for a com-
parative evaluationofdifferent lead compounds, butconsider-
ingthatleadcanreplacecalciumatfunctionally importantbin-
dingsites, itismostlikelythatthebiochemicallyeffectivespecies
oflead isPb2+. Though inhalation experiments withaerosolsof
cadmium didnot show noticeable differences betweenthecar-
cinogenicitiesofCdCl2, CdO,andCdS,themetallothione-bound
and cytosolic fractions ofcadmium in lung were much less in
CdS-exposed than in CdCl2- or CdO-exposed rats. Thus, it
seems that these fractions are not a reliable measure of the
bioavailability ofcadmiumforthecarcinogenicprocessbecause
cadmiuminotherfractions mayalsobeimportantcontributory
factors. Compared with CdO orCdCl2, afterexposure to CdS
ratshadahigherproportionofpulmonarycadmiuminthenon-
cytosolic fractions (cell debris, nuclear, mitochondrial
microsomalcomponents)where, atleastpartofcadmiummight
be Cd2+ bound to structural macromolecules. CdS particles
might also contributed tothecarcinogenic process.
Because soluble beryllium compounds precipitate in ex-
tracellular fluids, phagocytosis is the important mechanism of
cellularuptakeanddissolutionwithincellsisthekeycondition
for carcinogenicity. Phagocytosis and cellular dissolution are
also important for all nickel compounds with theexception of
nickel carbonyl. Membranes are no barriers against the lipo-
philicandvolatilenickelcarbonyl, buttheinefficientmembrane
transport ofNi2+ dissociated from soluble nickel compounds
allows timeforclearanceandpreventsgenotoxicdamage. Con-
ditionsareparticularly fivorable forNi3S2, whichhasadissolu-
tionhalf-timeof34daysinserumand21 daysincytosol, andits
phagocytosis by facultative phagocytes is 7-fold higher than
phagocytosisofthenoncarcinogenic, amorphousNiS. However,
phagocytosisanddissolution isnottheonlydeterminantofcar-
cinogenicity. The carcinogenic crystalline NiS has an 8-fold
higherphagocytic indexand29-fold lowercytosolicdissolution
ratethanamorphous NiS. Thus, whencells are surroundedby
equivalentconcentrationsofc7stallineandamorphousNiS, the
intracellular release ofofNi2 should be 3.6 times more from
the amorphous form than from the crystalline form. Never-
theless, only the crystalline form induced morphological
transformation.
Differences in the pharmacokinetics of metals from one
species toanotherinadministration routes, dose, andexposure
schedule may contribute to differences in the carcinogenic
reponse of test animals and exposed human populations.
However, carcinogenic exposure tometalsisaccompaniedby a
common reaction in both humans and experimental animals.
Epidemiological studies have confirmedthatmetals increased
cancerincidencewhenexposure wasinthetoxicrange. Thein-
creasedincidenceoflungcancerinarsenic-exposedpopulations
wasregularly associatedwithlesionsofskinandmucousmem-
branes. Proteinuria incadmium-exposedworkers, ulcerationof
thenasal septuminworkersexposedtochromium, andchronic
respiratoryirritationinnickel-exposedworkerswerefrequent-
lyrecordedinworkplaceswheretherewasanexcessofmortality
from respiratory cancer. Thepresenceofnongenotoxic effects
inbothexposedpopulationsandexperimental animalsandalso
negativeorlowmutagenicity inSalmonellaandmammaliancell
assays suggest that metals are with the possible exception of
chromium, promoters ratherthaninitiators andthereforetheir
carcinogenicity depends on the threshold of toxicity. The
nongenotoxicmechanismmayexplainwhyanimalexperiments
gave someevidence forthecarcinogenicity ofberyllium, lead,
cobalt, manganese, andzinc, andepidemiological studies were
either ambiguous or negative. In agreement with this view,
epidemiological studies, especially the sequence offollow-up
studiesindicatethatimprovementinthecontrolofoccupational
exposuretoarsenic, cadmium, andnickelwasuniformlyfollow-
edby adecrease in SMRs, often to the control level.
The author is grateful to The Mining Association of Canada for financial
assistanceandtoDr. StanleyWnittforhelpfuldiscussionandcriticalcomments
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